1
|
Wu JJ, Xiang B, Bai J, Li WW, Liu YJ, Xiang H, Qu LF. [Analysis of types and treatment methods of cervical massive hemorrhage]. Zhonghua Yi Xue Za Zhi 2021; 101:2283-2287. [PMID: 34333942 DOI: 10.3760/cma.j.cn112137-20210109-00063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To summarize the classification and clinical treatment experience of cervical massive hemorrhage in multiple centers. Methods: From April 2012 to October 2020, clinical data of 42 patients with cervical massive hemorrhage were retrospectively analyzed, including 27 cases from Shanghai Changzheng Hospital, 7 cases from Hunan Provincial People's Hospital, 4 cases from Longkou People's Hospital and 4 cases from Laizhou People's Hospital. According to bleeding position (P), bleeding vessel (V), cerebral blood supply (C), and the presence or absence of associated injury (A), 42 patients were classified as "PVCA", and summarize the methods of pre-hospital emergency and in-hospital treatment based on the "ABC" treatment principles: airway rebuild (A), effective arterial hemostasis and bleeding stop (B), and cerebral blood flow reconstruction within the time window (C). Results: Within the 42 cases of cervical massive hemorrhage, there were 3 cases of type P1 (below cricoid cartilage), 28 cases of type P2 (cricoid cartilage-mandibular angle), 11 cases of type P3 (mandibular angle-skull base); 22 cases of type V1 (arterial hemorrhage), 11 cases of type V2 (main venous hemorrhage), 7 cases of type V3 (simple superficial vein or small artery hemorrhage), 2 cases of type V4 (mixed arteriovenous hemorrhage); 5 cases of type C0 (no symptoms of cerebral ischemia and neurological dysfunction), 33 cases of type C1 (transient cerebral ischemia without sensory disturbance), 4 cases of type C2 (symptoms of cerebral ischemia and neurological dysfunction); 39 cases of type A0 (no other system damage was involved) and 3 cases of type A1 (combined with other system damage). All 42 patients received operations, 25 patients received open surgery of vascular reconstruction+hematoma/foreign body removal (7 cases of vascular ligation, 14 cases of direct suture repair, 4 cases of vascular interposition), 17 patients received hybrid surgery (carotid angiography+covered stent repair+hematoma/foreign body removal). The surgical technique success rate the was 100%. All the hemorrhagic shock was corrected, hematoma compression was relieved, and the symptoms of cephalic ischemia were improved. There were 4 cases of local cranial nerve injury, 1 case of incision hematoma and 6 cases of postoperative hyper perfusion. During the average 14.3 months follow-up, there was no operation related myocardial infarction, stroke or death, no re-rupture or re-dissection, and 50% asymptomatic restenosis was found in 1 case one year after received covered stent endovascular repair. Conclusion: Based on the "PVCA" classification and "ABC" treatment principle, it is safe and effective to rescue cervical massive hemorrhage.
Collapse
Affiliation(s)
- J J Wu
- Department of Vascular & Endovascular Surgery, Changzheng Hospital Affiliated to Naval Medical University, Shanghai 200003, China
| | - B Xiang
- Department of Interventional Vascular Surgery, Hunan Provincial People's Hospital, Changsha 410005, China
| | - J Bai
- Department of Vascular & Endovascular Surgery, Changzheng Hospital Affiliated to Naval Medical University, Shanghai 200003, China
| | - W W Li
- Department of Vascular & Endovascular Surgery, Longkou People's Hospital, Longkou 265701, China
| | - Y J Liu
- Department of Cardiovascular Surgery, Laizhou People's Hospital, Laizhou 261400, China
| | - H Xiang
- Department of Interventional Vascular Surgery, Hunan Provincial People's Hospital, Changsha 410005, China
| | - L F Qu
- Department of Vascular & Endovascular Surgery, Changzheng Hospital Affiliated to Naval Medical University, Shanghai 200003, China
| |
Collapse
|
2
|
Lin GH, Li LJ, Xiang H, Ye J, Xiang HP, Li ZQ, Liu XX. Spiroorthocarbonate as shrinkage resistance for UV-curing 3D printing: UV-curing kinetics, mechanical properties and volume shrinkage. EXPRESS POLYM LETT 2021. [DOI: 10.3144/expresspolymlett.2021.94] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
3
|
Glazer R, Gao S, Yuan H, Ranjit S, Lu J, Xiang H, Bhattacharya A, Brandish P, Levi M. Targeting immune tolerance and stromal fibrosis with an LXR agonist in a conditional transgenic model of mammary fibrosis. Eur J Cancer 2020. [DOI: 10.1016/s0959-8049(20)31117-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
4
|
Zhao CS, Yang Y, Yang ST, Xiang H, Ge YR, Zhang ZS, Zhao Y, Yu Q. Effects of spatial variation in water quality and hydrological factors on environmental flows. Sci Total Environ 2020; 728:138695. [PMID: 32570312 DOI: 10.1016/j.scitotenv.2020.138695] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/04/2019] [Revised: 04/10/2020] [Accepted: 04/12/2020] [Indexed: 06/11/2023]
Abstract
Environmental flow is the quantity, timing, and quality of water flows required to sustain freshwater and estuarine ecosystems and the human livelihoods and well-being that depend on these ecosystems. Environmental flows (e-flows) are crucial parameters for ecosystem restoration. Understanding the effects of spatial variation in the hydrological and water quality factors on e-flows aids the determination of recovery prior areas and helps to improve the success rate of ecosystem restoration projects. However, few studies have investigated the effects, which severely hinder the restoration of aquatic ecosystems and the sustainable use of water resources in inland waters. This paper therefore presents a framework for studying such effects. Spatial autocorrelation, a geostatistical method, is used to analyze the spatial variation in the hydrological and water quality factors and to further analyze the effects of various factors on the spatial heterogeneity of e-flows. Four different methods including the Tennant method, wetted perimeter method, AEHRA, and integrated water quality method are integrated to comprehensively evaluate e-flows. The former three methods consider the demands of biota on the streamflow, whereas the latter considers the demands on both the streamflow and the water quality. The results show that the Tennant and wetted perimeter methods, which focus on the statistics of only streamflow, result in similar spatial distribution of e-flows; the AEHRA and integrated water quality method, which consider the effects of water quality and other hydrological factors such as flow velocity and water depth on fish, also result in a similar spatial variation. Consideration of both demands on the hydrological factors and the water quality environmental factors makes the integrated water quality method more practical, particularly in developing regions with excessive pollutant discharge into rivers. In addition, spatial variation in the hydrological and water quality factors influenced the presence of principal fish species and consequently affected the e-flows. Of the 37 water quality factors identified, water transparency had a negative impact on e-flow because the increase in transparency could reduce the number of principal fish species. Of the four hydrological factors, flow velocity and river width had positive impacts on fish because the increase in flow velocity can provide breeding sites and habitats for more fish, respectively, both of which result in increases in the numbers of principal fish species. We found that spatial variation in the hydrology and water quality factors had a profound impact on the living environments of aquatic organisms; negative changes in these factors lowered the survival probability of principal species, which changed the hierarchy and structure of the ecosystems and thus led to variation in e-flows. The results can provide priori knowledge for e-flow methods selection and a reference for ecosystem restoration helping improve the success rate of project elsewhere in the world.
Collapse
Affiliation(s)
- C S Zhao
- Engineering Research Center of Ministry of Education on Groundwater Pollution Control and Remediation, College of Water Sciences, Beijing Normal University, Beijing 100875, PR China; College of Water Sciences, Beijing Key Laboratory of Urban Hydrological Cycle and Sponge City Technology, Beijing Normal University, Beijing 100875, PR China; ICube, UdS, CNRS (UMR 7357), 300 Bld Sebastien Brant, CS 10413, 67412 Illkirch, France
| | - Y Yang
- Engineering Research Center of Ministry of Education on Groundwater Pollution Control and Remediation, College of Water Sciences, Beijing Normal University, Beijing 100875, PR China; College of Water Sciences, Beijing Key Laboratory of Urban Hydrological Cycle and Sponge City Technology, Beijing Normal University, Beijing 100875, PR China
| | - S T Yang
- Engineering Research Center of Ministry of Education on Groundwater Pollution Control and Remediation, College of Water Sciences, Beijing Normal University, Beijing 100875, PR China; College of Water Sciences, Beijing Key Laboratory of Urban Hydrological Cycle and Sponge City Technology, Beijing Normal University, Beijing 100875, PR China.
| | - H Xiang
- Jinan Survey Bureau of Hydrology and Water Resources, Jinan 250013, PR China
| | - Y R Ge
- Jinan Survey Bureau of Hydrology and Water Resources, Jinan 250013, PR China
| | - Z S Zhang
- Jinan Survey Bureau of Hydrology and Water Resources, Jinan 250013, PR China
| | - Y Zhao
- Jinan Survey Bureau of Hydrology and Water Resources, Jinan 250013, PR China
| | - Q Yu
- State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau, Institute of Soil and Water Conservation, Northwest A&F University, Yangling 712100, Shaanxi, PR China; School of Life Sciences, University of Technology Sydney, Sydney 2000, NSW, Australia
| |
Collapse
|
5
|
Ouyang S, Yao YH, Zhang ZM, Liu JS, Xiang H. Curcumin inhibits hypoxia inducible factor-1α-induced inflammation and apoptosis in macrophages through an ERK dependent pathway. Eur Rev Med Pharmacol Sci 2020; 23:1816-1825. [PMID: 30840308 DOI: 10.26355/eurrev_201902_17145] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE Atherosclerosis, a kind of peripheral arterial disease with chronic inflammation, leads to the dysfunction of the vascular system and many other diseases. Hypoxia has been proven to participate in the progression of atherosclerosis, while curcumin can inhibit hypoxia-inducible factor 1α (HIF-1α). However, the underlying mechanisms are still elusive. PATIENTS AND METHODS qRT-PCR was used to examine the expression of HIF-1α, IL-6 and TNFα of macrophages under hypoxic condition. Western blot was applied to examine the changes of HIF-1α, ERK and p-ERK after treatment with curcumin. Oli Red O staining and enzymatic assay were used to examine the lipid and total cholesterol in macrophages, respectively. ELISA was used to examine the release of IL-6 and TNFα by macrophages. FACS and MTT assays were applied to examine the apoptosis and proliferation of macrophages. RESULTS Here, we found curcumin inhibited the expression of HIF-1α at the protein level in macrophages under hypoxic condition and curcumin and HIF-1α inhibitors repressed the total cholesterol and lipid level in macrophage under hypoxic condition. Moreover, curcumin also decreased the expression of HIF-1α downstream genes, VEGF, HMOX1, ROS and PDGF. Then, the data show the HIF-1α-induced apoptosis and inflammation of macrophages were inhibited by curcumin. Curcumin also rescued the proliferation defect of macrophages caused by hypoxia. Furthermore, we found it inhibited the expression of HIF-1α via ERK signaling pathway. CONCLUSIONS We describe that curcumin inhibited the HIF-1α-induced apoptosis and inflammation of macrophages via ERK signaling pathways. These results suggest curcumin can be used for the treatment of atherosclerosis.
Collapse
Affiliation(s)
- S Ouyang
- Department of Interventional Vascular Surgery, People's Hospital of Hunan Province, Changsha, P. R. China.
| | | | | | | | | |
Collapse
|
6
|
Chen YL, Meng L, Yan GL, Yang ZZ, Huang ZP, Zhang YS, Zhao Z, Wang CC, Bao Y, Xiang H, Yin H, Chen LF, Xiong YY, Wang L, Li WM. [Prognostic significance of early molecular response after second-line treatment with dasatinib of chronic myeloid leukemia patients]. Zhonghua Xue Ye Xue Za Zhi 2020; 40:608-611. [PMID: 32397028 PMCID: PMC7364892 DOI: 10.3760/cma.j.issn.0253-2727.2019.07.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Affiliation(s)
- Y L Chen
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - L Meng
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - G L Yan
- Xiangyang Central Hospital, Xiangyang 441021, China
| | - Z Z Yang
- Suizhou Central Hospital, Suizhou 441300, China
| | - Z P Huang
- Jingzhou Central Hospital, Jingzhou 434020, China
| | - Y S Zhang
- The First People's Hospital of Jingzhou, Jingzhou 434000, China
| | - Z Zhao
- MinDa Hospital Affiliated to Hubi Institute for Nationalities, Enshi 445000, China
| | - C C Wang
- Shiyan Taihe Hospital, Shiyan 442000, China
| | - Y Bao
- The First People's Hospital of Xiangyang, Xiangyang 441000, China
| | - H Xiang
- Central Hospital of Enshi Autonomous Prefecture, Enshi 445000, China
| | - H Yin
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - L F Chen
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - Y Y Xiong
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - L Wang
- The First People's Hospital of Jingmen, Jingmen 448000, China
| | - W M Li
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| |
Collapse
|
7
|
Xiang H, Liu Z, Zhou YB, Yao Q, Jin L, Xue BX. [Effects of long non-coding RNA FLJ37505 on the proliferation and migration of bladder cancer cells]. Zhonghua Yi Xue Za Zhi 2020; 100:1249-1254. [PMID: 32344498 DOI: 10.3760/cma.j.cn112137-20190728-01676] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To examine the expression of long-chain non-coding RNA (lncRNA) FLJ37505 in bladder cancer tissues and cell lines, and to analyze the molecular mechanism of FLJ37505 to inhibit the proliferation and migration of bladder cancer cells. Methods: Quantitative Real-time PCR(qPCR) was used to analyze the relative expression of FLJ37505 in 63 cases of bladder cancer tissues and bladder cancer cell lines (T24, J82, 5637, BIU-87 and UM-UC-3). The bladder cancer cell lines with the least expression of FLJ37505 were divided into control group (transfected with blank plasmid) and FLJ37505 group (transfected with a plasmid carrying the FLJ37505 sequence) according to random number method. MTS assay and scratch assay were used to detect the effect of up-regulation of FLJ37505 expression on cell proliferation and migration. Bioinformatics predicts the target gene of FLJ37505. The dual luciferase reporter system detects the binding of FLJ37505 to the target gene. qPCR and Western blot were used to detect the effect of FLJ37505 on the expression of target gene. Results: Compared with adjacent tissues, FLJ37505 expression was lower in bladder cancer tissue [(4.90±0.79) vs (0.89±0.28), P<0.05]. Compared with human normal bladder tubular epithelial cells, the expression of FLJ37505 was lower in bladder cancer cell lines (P<0.05), and FLJ37505 has the lowest expression in UM-UC-3 cells (P<0.01). Compared with the control group, the expression of FLJ37505 in UM-UC-3 cells of FLJ37505 group was higher [(0.79±0.04) vs (9.92±1.17), P<0.01]. Compared with the control group, the proliferation ability of UM-UC-3 cells in FLJ37505 group was inhibited (P<0.05), and the cell migration ability was also inhibited (P<0.01). Bioinformatics showed that the target gene of FLJ37505 is miR-203a-3p, and the target gene of miR-203a-3p is inositol polyphosphate 4-phosphatase typeⅡ (INPP4B). The dual luciferase reporter gene system showed that FLJ37505 could complement the miR-203a-3p (P<0.01), and miR-203a-3p could complement the INPP4B mRNA (P<0.01). Compared with the control group, the expression of miR-203a-3p was lower [(1.00±0.05) vs (0.20±0.02), P<0.01], the expression of INPP4B in mRNA and protein levels of UM-UC-3 cells in FLJ37505 group was significantly increased (all P<0.01). Conclusions: The expression of FLJ37505 was significantly decreased in bladder cell carcinoma and bladder cancer cells. Up-regulation of FLJ37505 significantly inhibits the proliferation and migration of bladder cell carcinoma UM-UC-3 cells, and the mechanism might be up-regulating the expression of the INPP4B gene by adsorbing miR-203a-3p.
Collapse
Affiliation(s)
- H Xiang
- Department of Urology, the Second Affiliated Hosptital of Soochow University, Suzhou 215004, China
| | - Z Liu
- Department of Endocrinology, the First Affiliated Hosptital of Soochow University, Suzhou 215006, China
| | - Y B Zhou
- Department of Urology, the Second Affiliated Hosptital of Soochow University, Suzhou 215004, China
| | - Q Yao
- Department of Urology, the Second Affiliated Hosptital of Soochow University, Suzhou 215004, China
| | - L Jin
- Department of Urology, the Second Affiliated Hosptital of Soochow University, Suzhou 215004, China
| | - B X Xue
- Department of Urology, the Second Affiliated Hosptital of Soochow University, Suzhou 215004, China
| |
Collapse
|
8
|
Jin L, Lu MH, Dai GC, Yao Q, Xiang H, Wang LX, Xue BX, Liu X. O-GlcNAcylation promotes malignant phenotypes of bladder cancer cells. Neoplasma 2020; 67:880-888. [PMID: 32305058 DOI: 10.4149/neo_2020_191006n1009] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2019] [Accepted: 11/26/2019] [Indexed: 11/08/2022]
Abstract
O-GlcNAcylation (O-GlcNAc) is a posttranslational modification that is mediated by O-GlcNAc-transferase (OGT) and reversed by O-GlcNAcase (OGA). Increasing evidence indicates that protein O-GlcNAcylation is increased in various types of cancer. In the present study, we aimed to evaluate the expression and function of both OGT and OGA in bladder cancer cells in vitro and in vivo. Expression data of OGT and OGA at the mRNA level was obtained from the Oncomine database. Effects of OGT and OGA on cell proliferate, invasive, and migratory abilities were assessed using MTT, wound healing, cell invasive assay, and cell cycle analysis. In vivo assay was also performed in nude mice. The results revealed that the expression of OGT in bladder cancer tissues was higher than that of normal tissues, while the OGA level was found to be lower in cancer tissues. We also found that knockdown of OGT could inhibit cell proliferation, migration, invasion, and induce cell cycle arrest, while these are reversed when OGA is inhibited. We also observed that O-GlcNAcylation could promote tumor formation in vivo, compared with a negative control. In summary, this study describes the oncogenic role of O-GlcNAcylation in bladder cancer cells.
Collapse
Affiliation(s)
- L Jin
- Department of Urology, The Second Affiliated Hospital of Soochow University, Soochow University, Suzhou, China
| | - M H Lu
- Department of Medical Records, The Second Affiliated Hospital of Soochow University, Soochow University, Suzhou, China
| | - G C Dai
- Department of Urology, The Second Affiliated Hospital of Soochow University, Soochow University, Suzhou, China
| | - Q Yao
- Department of Urology, The Second Affiliated Hospital of Soochow University, Soochow University, Suzhou, China
| | - H Xiang
- Department of Urology, The Second Affiliated Hospital of Soochow University, Soochow University, Suzhou, China
| | - L X Wang
- Department of Urology, The Second Affiliated Hospital of Soochow University, Soochow University, Suzhou, China
| | - B X Xue
- Department of Urology, The Second Affiliated Hospital of Soochow University, Soochow University, Suzhou, China
| | - X Liu
- Department of Urology, The Second Affiliated Hospital of Soochow University, Soochow University, Suzhou, China
| |
Collapse
|
9
|
Bhandari A, Xiang H, Lechner-Scott J, Agzarian M. Central vein sign for multiple sclerosis: A systematic review and meta-analysis. Clin Radiol 2020; 75:479.e9-479.e15. [PMID: 32143784 DOI: 10.1016/j.crad.2020.01.011] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2019] [Accepted: 01/24/2020] [Indexed: 10/24/2022]
Abstract
AIMS To systematically review the diagnostic value of the central vein sign (CVS) in multiple sclerosis (MS) and to meta-analyse the proportion of positive lesions for CVS needed to distinguish MS from non-MS mimics. MATERIALS AND METHODS A literature review was performed and a proportion meta-analysis was performed to examine the proportion of the CVS in MS lesions. Studies reporting a threshold of the CVS containing lesions with 100% diagnostic accuracy were included in the meta-analysis. This was compared to MS mimics in order to establish the discriminative value of the CVS. RESULTS The CVS was found to be viable at lower field strengths (3 T and 1.5 T) and automated analysis is currently less accurate than manual counting. Five studies were included for the proportional meta-analysis. From the analysis, a proportion of 45% of lesions having the CVS was suggested given that the findings that the weighted proportion was 46.4% (95% confidence interval [CI]: of 40.3%-52.6%) with low heterogeneity (I2 = 0.0%; p=0.5). CONCLUSION Although the CVS is a clinically relevant and viable sign, further work is needed to integrate this into the existing diagnostic criteria. As manual determination is a time-consuming process, the development of automated methods will be beneficial. With improvements in computational imaging techniques, the CVS will have an important role in the diagnosis and differentiation of MS.
Collapse
Affiliation(s)
- A Bhandari
- Department of Anatomy, College of Medicine and Dentistry, James Cook University, Townsville, Queensland, Australia; Townsville University Hospital, Townsville, Queensland, Australia.
| | - H Xiang
- Department of Anatomy, College of Medicine and Dentistry, James Cook University, Townsville, Queensland, Australia
| | - J Lechner-Scott
- Hunter Medical Research Institute, Newcastle, Australia; Faculty of Medicine and Public Health, The University of Newcastle, Newcastle, Australia; Department of Neurology, John Hunter Hospital, Newcastle, Australia
| | - M Agzarian
- South Australia Medical Imaging, Flinders Medical Centre, Adelaide, Australia; College of Medicine & Public Health, Flinders University, Adelaide, Australia
| |
Collapse
|
10
|
He XY, Xu L, Li CL, Xiang H. [Brain epithelioid glioblastoma with pulmonary metastasis: report of a case]. Zhonghua Bing Li Xue Za Zhi 2019; 48:418-420. [PMID: 31104691 DOI: 10.3760/cma.j.issn.0529-5807.2019.05.022] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- X Y He
- Department of Pathology, Zhejiang Quhua Hospital, Zhejiang Province, Quzhou 324004, China
| | - L Xu
- Hangzhou Dean Medical Inspection Center, Hangzhou 310000, China
| | - C L Li
- Department of Pathology, Zhejiang Quhua Hospital, Zhejiang Province, Quzhou 324004, China
| | - H Xiang
- Department of Pathology, the First Affiliated Hospital, Zhejiang University, Hangzhou 310003, China
| |
Collapse
|
11
|
Zhao CS, Yang Y, Yang ST, Xiang H, Wang F, Chen X, Zhang HM, Yu Q. Impact of spatial variations in water quality and hydrological factors on the food-web structure in urban aquatic environments. Water Res 2019; 153:121-133. [PMID: 30708191 DOI: 10.1016/j.watres.2019.01.015] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/17/2018] [Revised: 01/15/2019] [Accepted: 01/19/2019] [Indexed: 06/09/2023]
Abstract
Global aquatic ecosystems are essential to human existence and have deteriorated seriously in recent years. Understanding the influence mechanism of habitat variation on the structure of the food-web allows the effective recovery of the health of degraded ecosystems. Whereas most previous studies focused on the selection of driving habitat factors, the impact of habitat variation on the food-web structure was rarely studied, resulting in the low success rate of ecosystem restoration projects globally. This paper presents a framework for exploring the effects of spatial variations in water quality and hydrological habitat factors on the food-web structure in city waters. Indices for the evaluation of the food-web structure are first determined by integrating model-parameter extraction via literature refinement. The key water quality and hydrological factors are then determined by coupling canonical correspondence analysis with partial least squares regression. Their spatial variation is investigated using spatial autocorrelation. Finally, fuzzy clustering is applied to analyze the influence of the spatial variations in water quality and hydrological factors on the food-web structure. The results obtained in Ji'nan, the pilot city of water ecological civilization in China, show that the Shannon diversity index, connectance index, omnivory index, and the ratio of total primary production to the total respiration are important indicators of food-web structural change. They show that the driving factors affecting the aquatic food-web structure in Ji'nan are hydrological factors (e.g., river width, water depth, and stream flow), physical aspects of water quality (e.g., air temperature, water temperature, electrical conductivity, and transparency), and chemical aspects (e.g., potassium, dissolved oxygen, calcium, and total hardness). They also show that the stability of the food-web is more prone to spatial variations in water quality than in hydrological factors. Higher electrical conductivity, potassium, total hardness, and air temperature lead to deteriorated food-web structures, whereas better transparency improves structure and stability. We found that water and air temperature are the most important factors in the spatial variation of the food-web structure in the study area, followed by total hardness. Transparency is the least important factor. Large disparities and varied spatial distributions exist in the driving effects of water quality and hydrological factors across regions attributable to differences in geographical environments, water salinity (fresh vs. sea water), and environmental factors (e.g., water pollution). The above methods and results serve as a theoretical and scientific basis for a high success rate of aquatic ecosystem restoration projects in the study area and other cities worldwide.
Collapse
Affiliation(s)
- C S Zhao
- College of Water Sciences, Beijing Key Laboratory of Urban Hydrological Cycle and Sponge City Technology, Beijing Normal University, Beijing, 100875, PR China; ICube, UdS, CNRS (UMR 7357), 300 Bld Sebastien Brant, CS 10413, 67412, Illkirch, France
| | - Y Yang
- College of Water Sciences, Beijing Key Laboratory of Urban Hydrological Cycle and Sponge City Technology, Beijing Normal University, Beijing, 100875, PR China
| | - S T Yang
- College of Water Sciences, Beijing Key Laboratory of Urban Hydrological Cycle and Sponge City Technology, Beijing Normal University, Beijing, 100875, PR China.
| | - H Xiang
- Jinan Survey Bureau of Hydrology and Water Resources, Jinan, 250013, PR China
| | - F Wang
- Jinan Survey Bureau of Hydrology and Water Resources, Jinan, 250013, PR China
| | - X Chen
- Jinan Survey Bureau of Hydrology and Water Resources, Jinan, 250013, PR China
| | - H M Zhang
- Dongying Bureau of Hydrology and Water Resources, Dongying, 257000, PR China
| | - Q Yu
- State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau, Institute of Soil and Water Conservation, Northwest A&F University, Yangling, 712100, Shaanxi, China; School of Life Sciences, University of Technology Sydney, Sydney, 2000, NSW, Australia
| |
Collapse
|
12
|
Chen YL, Wang L, Yan GL, Yang ZZ, Huang ZP, Zhang YS, Zhao Z, Wan CC, Bao Y, Xiang H, Yin H, Chen LF, Xiong YY, Meng L, Li WM. [Efficacy and safety of domestic dasatinib as second-line treatment for chronic myeloid leukemia patients in the chronic phase]. Zhonghua Xue Ye Xue Za Zhi 2019; 40:98-104. [PMID: 30831623 PMCID: PMC7342660 DOI: 10.3760/cma.j.issn.0253-2727.2019.02.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Abstract
目的 探讨国产酪氨酸激酶抑制剂(TKI)达沙替尼(商品名:依尼舒)二线治疗慢性髓性白血病慢性期(CML-CP)患者的疗效及安全性。 方法 回顾性分析2016年3月至2018年7月湖北省CML协作组成员医院收治的二线服用国产达沙替尼的CML-CP患者的病例资料,统计患者治疗3、6和12个月时最佳反应率、累积完全细胞遗传学反应(CCyR)率、累积主要分子学反应(MMR)率、无进展生存(PFS)、无事件生存(EFS)情况及不良反应情况。 结果 共纳入83例CML-CP患者,中位随访时间为23(4~45)个月,达沙替尼治疗3、6、12个月最佳反应率分别为77.5%(54/71)、72.6%(61/75)、60.7%(51/69)。至随访截止,累积CCyR率、MMR率分别为65.5%(55/80)、57.1%(48/73),达CCyR和MMR的中位时间均为3个月。随访时间内,PFS率为94.0%(79/83),EFS率为77.4%(65/83)。国产达沙替尼最常见非血液学不良反应为水肿(32.5%),其次为皮疹瘙痒(18.1%)、乏力(13.3%),血液学不良反应主要有血小板减少(31.3%)、白细胞减少(19.3%)和贫血(6.0%)。 结论 国产达沙替尼二线治疗CML-CP患者具有较好的疗效及安全性,可作为CML-CP患者的治疗选择。
Collapse
Affiliation(s)
- Y L Chen
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - L Wang
- The First People's Hospital of Jingmen, Jingmen 448000, China
| | - G L Yan
- Xiangyang Central Hospital, Xiangyang 441021, China
| | - Z Z Yang
- Suizhou Central Hospital, Suizhou 441300, China
| | - Z P Huang
- Jingzhou Central Hospital, Jingzhou 434020, China
| | - Y S Zhang
- The First People's Hospital of Jingzhou, Jingzhou 434000, China
| | - Z Zhao
- Min Da Hospital Affiliated to Hubei Institute for Nationalities, Enshi 445000, China
| | - C C Wan
- Shiyan Taihe Hospital, Shiyan 442000, China
| | - Y Bao
- The First People's Hospital of Xiangyang, Xiangyang 441000, China
| | - H Xiang
- Central Hospital of Enshi Autonomous Prefecture, Enshi 445000, China
| | - H Yin
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - L F Chen
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - Y Y Xiong
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - L Meng
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - W M Li
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| |
Collapse
|
13
|
Zhao CS, Yang Y, Yang ST, Xiang H, Zhang Y, Wang ZY, Chen X, Mitrovic SM. Predicting future river health in a minimally influenced mountainous area under climate change. Sci Total Environ 2019; 656:1373-1385. [PMID: 30625666 DOI: 10.1016/j.scitotenv.2018.11.430] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/27/2018] [Revised: 11/28/2018] [Accepted: 11/28/2018] [Indexed: 06/09/2023]
Abstract
It has been shown that climate change impacts the overall health of a river's ecosystem. Although predicting river health under climate change would be useful for stakeholders to adapt to the change and better conserve river health, little research on this topic exists. This paper presents a methodology predicting river health under different climate change scenarios. First, a multi-source, distributed, time-variant gain hydrological model (MS-DTVGM) was used to predict the runoff from a mountainous river in eastern China using the data from three existing IPCC5 climate change models (RCP2.6, RCP4.5, and RCP8.4). Next, a model was developed to predict the river's water quality under these scenarios. Finally, a multidimensional response model utilizing hydrology, water quality, and biology was used to predict the river's biological status and ascertain the impact of climate change on its overall health. The river is in a mountainous area near Jinan City, one of China's first "pilot" cities recognized as a "healthy water ecological community." Our results predict that the overall health of the Yufu River, which is minimally influenced by human activities, will improve by 2030 due to the increased river flow due to an increase in rainfall frequency and subsequent peak runoff. However, the total nitrogen concentration is predicted to increase, which is a potential eutrophication risk. Therefore, effective control of nitrogen pollutants entering the river will be necessary. The increase in flow velocity (the annual average increase is ~0.5 m/s) is favorable for fish reproduction. Our methods and results will provide scientific guidance for policy makers and river managers and will help people to better understand how global climate change impacts river health.
Collapse
Affiliation(s)
- C S Zhao
- College of Water Sciences, Beijing Key Laboratory of Urban Hydrological Cycle and Sponge City Technology, Beijing Normal University, Beijing 100875, PR China; School of Geography, Faculty of Geographical Science, Beijing Normal University, Beijing 100875, PR China; ICube, UdS, CNRS (UMR 7357), 300 Bld Sebastien Brant, CS 10413, 67412 Illkirch, France
| | - Y Yang
- College of Water Sciences, Beijing Key Laboratory of Urban Hydrological Cycle and Sponge City Technology, Beijing Normal University, Beijing 100875, PR China
| | - S T Yang
- College of Water Sciences, Beijing Key Laboratory of Urban Hydrological Cycle and Sponge City Technology, Beijing Normal University, Beijing 100875, PR China; School of Geography, Faculty of Geographical Science, Beijing Normal University, Beijing 100875, PR China.
| | - H Xiang
- Jinan Survey Bureau of Hydrology and Water Resources, Jinan 250013, PR China
| | - Y Zhang
- School of Geography, Faculty of Geographical Science, Beijing Normal University, Beijing 100875, PR China
| | - Z Y Wang
- Jinan Survey Bureau of Hydrology and Water Resources, Jinan 250013, PR China
| | - X Chen
- Jinan Survey Bureau of Hydrology and Water Resources, Jinan 250013, PR China
| | - S M Mitrovic
- School of Life Sciences, Faculty of Science, University of Technology, Sydney, NSW 2007, Australia
| |
Collapse
|
14
|
Xiang H, Sun J, Tang X, Zeng K, Wu X. The effect and optimal parameters of repetitive transcranial magnetic stimulation on motor recovery in stroke patients: a systematic review and meta-analysis of randomized controlled trials. Clin Rehabil 2019; 33:847-864. [PMID: 30773896 DOI: 10.1177/0269215519829897] [Citation(s) in RCA: 32] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
OBJECTIVE The primary aim of this meta-analysis was to evaluate the effects of repetitive transcranial magnetic stimulation (rTMS) on limb movement recovery post-stroke and cortex excitability, to explore the optimal parameters of rTMS and suitable stroke population. Second, adverse events were also included. DATA SOURCES The databases of PubMed, EBSCO, MEDLINE, the Cochrane Central Register of Controlled Trials, EBM Reviews-Cochrane Database, the Chinese National Knowledge Infrastructure, and the Chinese Science and Technology Journals Database were searched for randomized controlled trials exploring the effects of rTMS on limb motor function recovery post-stroke before December 2018. REVIEW METHODS The effect sizes of rTMS on limb motor recovery, the effect size of rTMS stimulation parameters, and different stroke population were summarized by calculating the standardized mean difference (SMD) and the 95% confidence interval using fixed/random effect models as appropriate. RESULTS For the motor function assessment, 42 eligible studies involving 1168 stroke patients were identified. The summary effect size indicated that rTMS had positive effects on limb motor recovery (SMD = 0.50, P < 0.00001) and activities of daily living (SMD = 0.82, P < 0.00001), and motor-evoked potentials of the stimulated hemisphere differed according to the stimulation frequency, that is, the high-frequency group (SMD = 0.57, P = 0.0006), except the low-frequency group (SMD = -0.27, P = 0.05). No significant differences were observed among the stimulation parameter subgroups except for the sessions subgroup ( P = 0.02). Only 10 included articles reported transient mild discomfort after rTMS. CONCLUSIONS rTMS promoted the recovery of limb motor function and changed the cortex excitability. rTMS may be better for early and pure subcortical stroke patients. Regarding different stimulation parameters, the number of stimulation sessions has an impact on the effect of rTMS.
Collapse
Affiliation(s)
- Huifang Xiang
- 1 Department of Rehabilitation Medicine, Chonggang General Hospital, Chongqing, China
| | - Jing Sun
- 2 Department of Gastrointestinal Neonatal Surgery, Children's Hospital of Chongqing Medical University, Chongqing, China
| | - Xiang Tang
- 3 Department of Neurology, First Affiliated Hospital of Chongqing Medical University, Chongqing, China
| | - Kebin Zeng
- 3 Department of Neurology, First Affiliated Hospital of Chongqing Medical University, Chongqing, China
| | - Xiushu Wu
- 3 Department of Neurology, First Affiliated Hospital of Chongqing Medical University, Chongqing, China
| |
Collapse
|
15
|
Guangping L, Wei L, Xiang H, Shidai J, Dengshun M, Ziyi F, Jinhai T, Yongmei Y. Abstract P6-03-05: Not presented. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p6-03-05] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
This abstract was not presented at the conference.
Citation Format: Guangping L, Wei L, Xiang H, Shidai J, Dengshun M, Ziyi F, Jinhai T, Yongmei Y. Not presented [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P6-03-05.
Collapse
Affiliation(s)
- L Guangping
- The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China; The Dongtai Affiliated Hospital of Nantong University, Dongtai, Jiangsu, China; State Key Laboratory of Reproductive Medicine, The Research Center for Bone and Stem Cells, Nanjing Medical University, Nanjing, Jiangsu, China; Nanjing Maternal and Child Medical Institute, Affiliated Nanjing Maternity and Child Health Care Hospital, Nanjing Medical University, Nanjing, Jiangsu, China
| | - L Wei
- The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China; The Dongtai Affiliated Hospital of Nantong University, Dongtai, Jiangsu, China; State Key Laboratory of Reproductive Medicine, The Research Center for Bone and Stem Cells, Nanjing Medical University, Nanjing, Jiangsu, China; Nanjing Maternal and Child Medical Institute, Affiliated Nanjing Maternity and Child Health Care Hospital, Nanjing Medical University, Nanjing, Jiangsu, China
| | - H Xiang
- The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China; The Dongtai Affiliated Hospital of Nantong University, Dongtai, Jiangsu, China; State Key Laboratory of Reproductive Medicine, The Research Center for Bone and Stem Cells, Nanjing Medical University, Nanjing, Jiangsu, China; Nanjing Maternal and Child Medical Institute, Affiliated Nanjing Maternity and Child Health Care Hospital, Nanjing Medical University, Nanjing, Jiangsu, China
| | - J Shidai
- The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China; The Dongtai Affiliated Hospital of Nantong University, Dongtai, Jiangsu, China; State Key Laboratory of Reproductive Medicine, The Research Center for Bone and Stem Cells, Nanjing Medical University, Nanjing, Jiangsu, China; Nanjing Maternal and Child Medical Institute, Affiliated Nanjing Maternity and Child Health Care Hospital, Nanjing Medical University, Nanjing, Jiangsu, China
| | - M Dengshun
- The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China; The Dongtai Affiliated Hospital of Nantong University, Dongtai, Jiangsu, China; State Key Laboratory of Reproductive Medicine, The Research Center for Bone and Stem Cells, Nanjing Medical University, Nanjing, Jiangsu, China; Nanjing Maternal and Child Medical Institute, Affiliated Nanjing Maternity and Child Health Care Hospital, Nanjing Medical University, Nanjing, Jiangsu, China
| | - F Ziyi
- The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China; The Dongtai Affiliated Hospital of Nantong University, Dongtai, Jiangsu, China; State Key Laboratory of Reproductive Medicine, The Research Center for Bone and Stem Cells, Nanjing Medical University, Nanjing, Jiangsu, China; Nanjing Maternal and Child Medical Institute, Affiliated Nanjing Maternity and Child Health Care Hospital, Nanjing Medical University, Nanjing, Jiangsu, China
| | - T Jinhai
- The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China; The Dongtai Affiliated Hospital of Nantong University, Dongtai, Jiangsu, China; State Key Laboratory of Reproductive Medicine, The Research Center for Bone and Stem Cells, Nanjing Medical University, Nanjing, Jiangsu, China; Nanjing Maternal and Child Medical Institute, Affiliated Nanjing Maternity and Child Health Care Hospital, Nanjing Medical University, Nanjing, Jiangsu, China
| | - Y Yongmei
- The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China; The Dongtai Affiliated Hospital of Nantong University, Dongtai, Jiangsu, China; State Key Laboratory of Reproductive Medicine, The Research Center for Bone and Stem Cells, Nanjing Medical University, Nanjing, Jiangsu, China; Nanjing Maternal and Child Medical Institute, Affiliated Nanjing Maternity and Child Health Care Hospital, Nanjing Medical University, Nanjing, Jiangsu, China
| |
Collapse
|
16
|
Mei YY, Hai TJ, Wei L, Xiang H, Hao W, Ming ZX, An LX. Abstract P1-18-03: Phase I trial to assess the safety, pharmacokinetics and pharmacodynamics of receptor activator of nuclear factor-κB ligand inhibitor (TK006) in patients with bone metastases from breast cancer. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p1-18-03] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background
Within the bone microenvironment, tumor cells secrete factors that stimulate osteoblasts to express and secrete receptor activator of nuclear factor-κB ligand (RANKL), which binds to its receptor RANK on the surface of osteoclasts, thus enhancing the osteoclast-mediated bone resorption and promoting skeletal complications.TK006 is a fully human monoclonal antibody that binds and inhibits RANKL, thus inhibiting osteoclast-mediated bone destruction.
Objective
To investigate the safety, pharmacokinetics and pharmacodynamics of TK006 in patients with bone metastases from breast cancer.
Patients and methods
In this dose-escalating study, patients were sequentially enrolled into 60 mg, 120 mg, 180 mg single-dosing and 120 multiple-dosing cohorts. Before making dose escalation decision, the safety of TK006 during the 14-day period after dosing in the prior cohort must be confirmed. In the three single-dosing cohorts, patients were followed up for 16 weeks after dosing. In the 120 mg multiple-dosing cohort, patents were treated with 120 mg TK006 every 4 weeks for 3 times totally, and followed up for 20 weeks after the first dosing. The primary outcome was safety profile, and the secondary outcomes were pharmacokinetics, pharmacodynamics and immunogenicity. Pharmacodynamics was measured by level of serum bone alkaline phosphatase (BALP) and urine creatinine corrected cross-linked N-telopeptides of type I collagen (uNTX/Cr).
Patients aged 18 to 65 years with breast cancer related bone metastasis were eligible. It was planned to enroll 10 subjects in each cohort for a total sample size of 40 subjects.
Result
As of May 24 2018, the common adverse events (AEs) related to treatment (≥10%) included: hypocalcemia (25.0%), limbs pain (20.0%), gamma-glutamyl transferase increased (17.5%), lactate dehydrogenase increased (12.5%), alpha-hydroxybutyric dehydrogenase increased (12.5%), aspertate aminotransferase increased (12.5%), alanine aminotransferase (10.0%),osphyalgia (10.0%) toothache (10.0%) and hypertriglyceridemia (10%). Most adverse reactions were mild or moderate except one case of grade 3 hypertriglyceridemia and two cases of grade 3 gamma-glutamyl transferase increasement. No esteonecrosis of the jaw or treatment-related SAE was reported.
In the 60 mg single-dosing cohort, a significant reduction in median uNTX/Cr was observed as early as day 1, the nadir of median uNTX/Cr was reach at day 28 and started to return towards the baseline level at day 112 (Table 1).
Only modest decreasing from baseline in median bone-specific alkaline phosphatase was observed.
Table 1.Effects of 60 mg TK006 therapy on bone turnover markers uNTX/Cr, % change from baseline, medianBALP , % change from baseline, medianD1-38.6-4.7D7-63.01.7D14-55.30.2D28-69.2-0.2D56-57.9-12.1D84-33.4-0.4D1121.3-18.7
Ostalgia was measured by visual analogue scale (VAS). In the 60 mg single-dosing cohort, scores were reduced to 2 from 5 and 3 in two patients individually. No increasing in pain was observed in the remaining 8 patients.
Conclusion
These results suggested a potential therapeutic role for TK006 in patients with bone metastases from breast cancer.
Citation Format: Mei YY, Hai TJ, Wei L, Xiang H, Hao W, Ming ZX, An LX. Phase I trial to assess the safety, pharmacokinetics and pharmacodynamics of receptor activator of nuclear factor-κB ligand inhibitor (TK006) in patients with bone metastases from breast cancer [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P1-18-03.
Collapse
Affiliation(s)
- YY Mei
- The First Affiliated Hospital With Nanjing Medical University, Nanjing, Jiang Su, China
| | - TJ Hai
- The First Affiliated Hospital With Nanjing Medical University, Nanjing, Jiang Su, China
| | - L Wei
- The First Affiliated Hospital With Nanjing Medical University, Nanjing, Jiang Su, China
| | - H Xiang
- The First Affiliated Hospital With Nanjing Medical University, Nanjing, Jiang Su, China
| | - W Hao
- The First Affiliated Hospital With Nanjing Medical University, Nanjing, Jiang Su, China
| | - ZX Ming
- The First Affiliated Hospital With Nanjing Medical University, Nanjing, Jiang Su, China
| | - LX An
- The First Affiliated Hospital With Nanjing Medical University, Nanjing, Jiang Su, China
| |
Collapse
|
17
|
Ridley LJ, Han J, Xiang H. The "Bovine Aortic Arch": Time to Rethink the True Origin of the Term? AJNR Am J Neuroradiol 2019; 40:E7-E8. [PMID: 30679222 DOI: 10.3174/ajnr.a5924] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- L J Ridley
- Department of Radiology Concord Repatriation General Hospital Concord, New South Wales, Australia
| | - J Han
- Medical Imaging University of Sydney Sydney, New South Wales, Australia
| | - H Xiang
- Department of Radiology Concord Repatriation General Hospital Concord, New South Wales, Australia
| |
Collapse
|
18
|
Deng Z, Xiang H, Gao W. Significant association between paraoxonase 1 rs662 polymorphism and coronary heart disease : A meta-analysis in the Chinese population. Herz 2018; 45:347-355. [PMID: 30128909 DOI: 10.1007/s00059-018-4737-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2018] [Revised: 06/02/2018] [Accepted: 07/18/2018] [Indexed: 11/27/2022]
Abstract
BACKGROUND A growing number of studies have suggested that the single nucleotide polymorphism (SNP) rs662 (G>A) in paraoxonase 1 (PON1) is significantly associated with susceptibility to coronary heart disease (CHD) in the Chinese population. To further evaluate the effects of the PON1 RS662 (G>A) polymorphism on the risk of CHD, we performed a meta-analysis in a Chinese population. METHODS PubMed, Embase, Wanfang Data, Chinese National Knowledge Infrastructure (CNKI) were searched to identify eligible studies. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were used to evaluate the strength of the associations between RS662 (G>A) and CHD. RESULT In the meta-analysis, we identified 14 articles, including a total of 4835 CHD patients and 5111 controls in the Chinese population. Our result showed that overall rs662 (G>A) was significantly associated with susceptibility to CHD in the Chinese population when compared with healthy controls. Furthermore, a G allele suggested an elevated risk of CHD. In the subgroup analyses stratified by ethnicity and geographic areas, significant associations were found in Chinese Han and South China, but not in North China. CONCLUSION The present meta-analysis suggests that rs662 (G>A) SNP in PON1 is associated with CHD risk; the G allele might be the risk allele for CHD susceptibility in the Chinese population. However, more research is required to make a definite conclusion.
Collapse
Affiliation(s)
- Z Deng
- Department of Pharmacy, The First College of Clinical Medical Science, China Three Gorges University and Yichang Central People'sHospital, 443000, Yichang, China.
| | - H Xiang
- Department of Laboratory Medicine, The First College of Clinical Medical Science, China Three Gorges University and Yichang Central People's Hospital, 443000, Yichang, China
| | - W Gao
- Central Experimental Laboratory and Yichang Key Laboratory of Ischemic Cardiovascular and Cerebrovascular Disease Translational Medicine, The First College of Clinical Medical Science, China Three Gorges University and Yichang Central People's Hospital, 443003, Yichang, China
| |
Collapse
|
19
|
Kelly S, Jahanshad N, Zalesky A, Kochunov P, Agartz I, Alloza C, Andreassen OA, Arango C, Banaj N, Bouix S, Bousman CA, Brouwer RM, Bruggemann J, Bustillo J, Cahn W, Calhoun V, Cannon D, Carr V, Catts S, Chen J, Chen JX, Chen X, Chiapponi C, Cho KK, Ciullo V, Corvin AS, Crespo-Facorro B, Cropley V, De Rossi P, Diaz-Caneja CM, Dickie EW, Ehrlich S, Fan FM, Faskowitz J, Fatouros-Bergman H, Flyckt L, Ford JM, Fouche JP, Fukunaga M, Gill M, Glahn DC, Gollub R, Goudzwaard ED, Guo H, Gur RE, Gur RC, Gurholt TP, Hashimoto R, Hatton SN, Henskens FA, Hibar DP, Hickie IB, Hong LE, Horacek J, Howells FM, Hulshoff Pol HE, Hyde CL, Isaev D, Jablensky A, Jansen PR, Janssen J, Jönsson EG, Jung LA, Kahn RS, Kikinis Z, Liu K, Klauser P, Knöchel C, Kubicki M, Lagopoulos J, Langen C, Lawrie S, Lenroot RK, Lim KO, Lopez-Jaramillo C, Lyall A, Magnotta V, Mandl RCW, Mathalon DH, McCarley RW, McCarthy-Jones S, McDonald C, McEwen S, McIntosh A, Melicher T, Mesholam-Gately RI, Michie PT, Mowry B, Mueller BA, Newell DT, O'Donnell P, Oertel-Knöchel V, Oestreich L, Paciga SA, Pantelis C, Pasternak O, Pearlson G, Pellicano GR, Pereira A, Pineda Zapata J, Piras F, Potkin SG, Preda A, Rasser PE, Roalf DR, Roiz R, Roos A, Rotenberg D, Satterthwaite TD, Savadjiev P, Schall U, Scott RJ, Seal ML, Seidman LJ, Shannon Weickert C, Whelan CD, Shenton ME, Kwon JS, Spalletta G, Spaniel F, Sprooten E, Stäblein M, Stein DJ, Sundram S, Tan Y, Tan S, Tang S, Temmingh HS, Westlye LT, Tønnesen S, Tordesillas-Gutierrez D, Doan NT, Vaidya J, van Haren NEM, Vargas CD, Vecchio D, Velakoulis D, Voineskos A, Voyvodic JQ, Wang Z, Wan P, Wei D, Weickert TW, Whalley H, White T, Whitford TJ, Wojcik JD, Xiang H, Xie Z, Yamamori H, Yang F, Yao N, Zhang G, Zhao J, van Erp TGM, Turner J, Thompson PM, Donohoe G. Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group. Mol Psychiatry 2018; 23:1261-1269. [PMID: 29038599 PMCID: PMC5984078 DOI: 10.1038/mp.2017.170] [Citation(s) in RCA: 412] [Impact Index Per Article: 68.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/17/2016] [Revised: 05/02/2017] [Accepted: 06/07/2017] [Indexed: 12/15/2022]
Abstract
The regional distribution of white matter (WM) abnormalities in schizophrenia remains poorly understood, and reported disease effects on the brain vary widely between studies. In an effort to identify commonalities across studies, we perform what we believe is the first ever large-scale coordinated study of WM microstructural differences in schizophrenia. Our analysis consisted of 2359 healthy controls and 1963 schizophrenia patients from 29 independent international studies; we harmonized the processing and statistical analyses of diffusion tensor imaging (DTI) data across sites and meta-analyzed effects across studies. Significant reductions in fractional anisotropy (FA) in schizophrenia patients were widespread, and detected in 20 of 25 regions of interest within a WM skeleton representing all major WM fasciculi. Effect sizes varied by region, peaking at (d=0.42) for the entire WM skeleton, driven more by peripheral areas as opposed to the core WM where regions of interest were defined. The anterior corona radiata (d=0.40) and corpus callosum (d=0.39), specifically its body (d=0.39) and genu (d=0.37), showed greatest effects. Significant decreases, to lesser degrees, were observed in almost all regions analyzed. Larger effect sizes were observed for FA than diffusivity measures; significantly higher mean and radial diffusivity was observed for schizophrenia patients compared with controls. No significant effects of age at onset of schizophrenia or medication dosage were detected. As the largest coordinated analysis of WM differences in a psychiatric disorder to date, the present study provides a robust profile of widespread WM abnormalities in schizophrenia patients worldwide. Interactive three-dimensional visualization of the results is available at www.enigma-viewer.org.
Collapse
Affiliation(s)
- S Kelly
- Imaging Genetics Center, Stevens Neuroimaging & Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA,Harvard Medical School, Boston, MA, USA,Imaging Genetics Center, Keck School of Medicine, University of Southern California, Marina del Rey, CA 90292, USA. E-mail:
| | - N Jahanshad
- Imaging Genetics Center, Stevens Neuroimaging & Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA
| | - A Zalesky
- Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne and Melbourne Health, Carlton South, VIC, Australia
| | - P Kochunov
- Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA
| | - I Agartz
- NORMENT, KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway,Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Stockholm, Sweden,Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway
| | - C Alloza
- University of Edinburgh, Edinburgh, UK
| | | | - C Arango
- Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM, CIBERSAM, Madrid, Spain
| | - N Banaj
- Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy
| | - S Bouix
- Department of Psychiatry, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
| | - C A Bousman
- Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne and Melbourne Health, Carlton South, VIC, Australia,Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia,Department of General Practice, The University of Melbourne, Parkville, VIC, Australia,Swinburne University of Technology, Melbourne, VIC, Australia
| | - R M Brouwer
- Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands
| | - J Bruggemann
- Neuroscience Research Australia and School of Psychiatry, University of New South Wales, Sydney, NSW, Australia
| | - J Bustillo
- University of New Mexico, Albuquerque, NM, USA
| | - W Cahn
- Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands
| | - V Calhoun
- The Department of Electrical and Computer Engineering, University of New Mexico, Albuquerque, NM, USA,The Mind Research Network, Albuquerque, NM, USA
| | - D Cannon
- Centre for Neuroimaging and Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, National University of Ireland Galway, Galway, Ireland
| | - V Carr
- Neuroscience Research Australia and School of Psychiatry, University of New South Wales, Sydney, NSW, Australia
| | - S Catts
- Discipline of Psychiatry, School of Medicine, University of Queensland, Herston, QLD, Australia
| | - J Chen
- Department of Computer Science and Engineering, The Ohio State University, Columbus, OH, USA
| | - J-x Chen
- Beijing Huilongguan Hospital, Beijing, China
| | - X Chen
- Worldwide Research and Development, Pfizer, Cambridge, MA, USA
| | | | - Kl K Cho
- Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea
| | - V Ciullo
- Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy
| | - A S Corvin
- Department of Psychiatry and Neuropsychiatric Genetics Research Group, Institute of Molecular Medicine, Trinity College Dublin, Dublin, Ireland
| | - B Crespo-Facorro
- University Hospital Marqués de Valdecilla, IDIVAL, Department of Medicine and Psychiatry, School of Medicine, University of Cantabria, Santander, Spain,CIBERSAM, Centro Investigación Biomédica en Red Salud Mental, Santander, Spain
| | - V Cropley
- Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne and Melbourne Health, Carlton South, VIC, Australia
| | - P De Rossi
- Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy,Department NESMOS, Faculty of Medicine and Psychology, University ‘Sapienza’ of Rome, Rome, Italy,Department of Neurology and Psychiatry, Sapienza University of Rome, Rome, Italy
| | - C M Diaz-Caneja
- Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM, CIBERSAM, Madrid, Spain
| | - E W Dickie
- Center for Addiction and Mental Health, Toronto, ON, Canada
| | - S Ehrlich
- Division of Psychological and Social Medicine and Developmental Neurosciences, Technische Universität Dresden, Faculty of Medicine, University Hospital C.G. Carus, Dresden, Germany
| | - F-m Fan
- Beijing Huilongguan Hospital, Beijing, China
| | - J Faskowitz
- Imaging Genetics Center, Stevens Neuroimaging & Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA
| | - H Fatouros-Bergman
- Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Stockholm, Sweden
| | - L Flyckt
- University of New South Wales, School of Psychiatry, Sydney, NSW, Australia,The University of Queensland, Queensland Brain Institute and Centre for Advanced Imaging, Brisbane, QLD, Australia
| | - J M Ford
- University of California, VAMC, San Francisco, CA, USA
| | - J-P Fouche
- Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa
| | - M Fukunaga
- Division of Cerebral Integration, National Institute for Physiological Sciences, Aichi, Japan
| | - M Gill
- Department of Psychiatry and Neuropsychiatric Genetics Research Group, Institute of Molecular Medicine, Trinity College Dublin, Dublin, Ireland
| | - D C Glahn
- Olin Neuropsychiatric Research Center, Institute of Living, Hartford Hospital and Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
| | - R Gollub
- Harvard Medical School, Boston, MA, USA,Departments of Psychiatry and Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - E D Goudzwaard
- Department of Psychiatry and Human Behavior, University of California Irvine, Irvine, CA, USA
| | - H Guo
- Zhumadian Psychiatry Hospital, Henan Province, China
| | - R E Gur
- Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA
| | - R C Gur
- Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA
| | - T P Gurholt
- NORMENT, KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - R Hashimoto
- Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Osaka, Japan,Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan
| | - S N Hatton
- Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia
| | - F A Henskens
- School of Electrical Engineering and Computer Science, University of Newcastle, Callaghan, NSW, Australia,Health Behaviour Research Group, University of Newcastle, Callaghan, NSW, Australia,Hunter Medical Research Institute, Newcastle, NSW, Australia
| | - D P Hibar
- Imaging Genetics Center, Stevens Neuroimaging & Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA
| | - I B Hickie
- Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia
| | - L E Hong
- Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA
| | - J Horacek
- National Institute of Mental Health, Klecany, Czech Republic,Third Faculty of Medicine, Charles University, Prague, Czech Republic
| | - F M Howells
- Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa
| | - H E Hulshoff Pol
- Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands
| | - C L Hyde
- Worldwide Research and Development, Pfizer, Cambridge, MA, USA
| | - D Isaev
- Imaging Genetics Center, Stevens Neuroimaging & Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA
| | - A Jablensky
- University of Western Australia, Perth, WA, Australia
| | - P R Jansen
- Erasmus University Medical Center, Rotterdam, The Netherlands
| | - J Janssen
- Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM, CIBERSAM, Madrid, Spain,Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands
| | - E G Jönsson
- NORMENT, KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway,Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Stockholm, Sweden
| | - L A Jung
- Laboratory for Neuroimaging, Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, Goethe University, Frankfurt/Main, Germany
| | - R S Kahn
- Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Z Kikinis
- Department of Psychiatry, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
| | - K Liu
- Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne and Melbourne Health, Carlton South, VIC, Australia
| | - P Klauser
- Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne and Melbourne Health, Carlton South, VIC, Australia,Brain and Mental Health Laboratory, Monash Institute of Cognitive and Clinical Neurosciences, School of Psychological Sciences and Monash Biomedical Imaging, Monash University, Clayton, VIC, Australia,Department of Psychiatry, Lausanne University Hospital (CHUV), University of Lausanne, Lausanne, Switzerland
| | - C Knöchel
- Laboratory for Neuroimaging, Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, Goethe University, Frankfurt/Main, Germany
| | - M Kubicki
- Departments of Psychiatry and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - J Lagopoulos
- Sunshine Coast Mind and Neuroscience Institute, University of the Sunshine Coast QLD, Australia, Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia
| | - C Langen
- Erasmus University Medical Center, Rotterdam, The Netherlands
| | - S Lawrie
- University of Edinburgh, Edinburgh, UK
| | - R K Lenroot
- Neuroscience Research Australia and School of Psychiatry, University of New South Wales, Sydney, NSW, Australia
| | - K O Lim
- Department of Psychiatry, University of Minnesota, Minneapolis, MN, USA
| | - C Lopez-Jaramillo
- Research Group in Psychiatry (GIPSI), Department of Psychiatry, Faculty of Medicine, Universidad de Antioquia, Mood Disorder Program, Hospital Universitario San Vicente Fundación, Medellín, Colombia
| | - A Lyall
- Department of Psychiatry, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA,Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | | | - R C W Mandl
- Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands
| | - D H Mathalon
- University of California, VAMC, San Francisco, CA, USA
| | | | - S McCarthy-Jones
- Department of Psychiatry, Trinity College Dublin, Dublin, Ireland
| | - C McDonald
- Centre for Neuroimaging and Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, National University of Ireland Galway, Galway, Ireland
| | - S McEwen
- Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, USA
| | | | - T Melicher
- Third Faculty of Medicine, Charles University, Prague, Czech Republic,The University of Texas Health Science Center at Houston, Houston, TX, USA
| | - R I Mesholam-Gately
- Harvard Medical School and Massachusetts Mental Health Center Public Psychiatry Division of the Beth Israel Deaconess, Medical Center, Boston, MA, USA
| | - P T Michie
- Hunter Medical Research Institute, Newcastle, NSW, Australia,The University of Newcastle, Newcastle, NSW, Australia,Schizophrenia Research Institute, Sydney, NSW, Australia
| | - B Mowry
- Queensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia and Queensland Centre for Mental Health Research, Brisbane and Queensland Centre for Mental Health Research, Brisbane, QLD, Australia
| | - B A Mueller
- Department of Psychiatry, University of Minnesota, Minneapolis, MN, USA
| | - D T Newell
- Department of Psychiatry, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
| | - P O'Donnell
- Worldwide Research and Development, Pfizer, Cambridge, MA, USA
| | - V Oertel-Knöchel
- Laboratory for Neuroimaging, Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, Goethe University, Frankfurt/Main, Germany
| | - L Oestreich
- Queensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia and Queensland Centre for Mental Health Research, Brisbane and Queensland Centre for Mental Health Research, Brisbane, QLD, Australia
| | - S A Paciga
- Worldwide Research and Development, Pfizer, Cambridge, MA, USA
| | - C Pantelis
- Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne and Melbourne Health, Carlton South, VIC, Australia,Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia,Schizophrenia Research Institute, Sydney, NSW, Australia,Centre for Neural Engineering (CfNE), Department of Electrical and Electronic Engineering, University of Melbourne, Parkville, VIC, Australia
| | - O Pasternak
- Departments of Psychiatry and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - G Pearlson
- Olin Neuropsychiatric Research Center, Institute of Living, Hartford Hospital and Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
| | - G R Pellicano
- Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy
| | - A Pereira
- The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC, Australia
| | | | - F Piras
- Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy,School of Biomedical Sciences, Faculty of Health, the University of Newcastle, Callaghan, NSW, Australia
| | - S G Potkin
- Department of Psychiatry and Human Behavior, University of California Irvine, Irvine, CA, USA
| | - A Preda
- Department of Psychiatry and Human Behavior, University of California Irvine, Irvine, CA, USA
| | - P E Rasser
- Hunter Medical Research Institute, Newcastle, NSW, Australia,Priority Centre for Brain and Mental Health Research, The University of Newcastle, Newcastle, NSW, Australia
| | - D R Roalf
- Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA
| | - R Roiz
- University Hospital Marqués de Valdecilla, IDIVAL, Department of Medicine and Psychiatry, School of Medicine, University of Cantabria, Santander, Spain,CIBERSAM, Centro Investigación Biomédica en Red Salud Mental, Santander, Spain
| | - A Roos
- SU/UCT MRC Unit on Anxiety and Stress Disorders, Department of Psychiatry, Stellenbosch University, Stellenbosch, South Africa
| | - D Rotenberg
- Center for Addiction and Mental Health, Toronto, ON, Canada
| | - T D Satterthwaite
- Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA
| | - P Savadjiev
- Departments of Psychiatry and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - U Schall
- Hunter Medical Research Institute, Newcastle, NSW, Australia,Priority Centre for Brain and Mental Health Research, The University of Newcastle, Newcastle, NSW, Australia
| | - R J Scott
- Hunter Medical Research Institute, Newcastle, NSW, Australia,School of Biomedical Sciences, Faculty of Health, the University of Newcastle, Callaghan, NSW, Australia
| | - M L Seal
- Murdoch Childrens Research Institute, The Royal Children’s Hospital, Parkville, VIC, Australia
| | - L J Seidman
- Harvard Medical School, Boston, MA, USA,Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA,Harvard Medical School and Massachusetts Mental Health Center Public Psychiatry Division of the Beth Israel Deaconess, Medical Center, Boston, MA, USA
| | - C Shannon Weickert
- Schizophrenia Research Institute, Sydney, NSW, Australia,Neuroscience Research Australia, Sydney, NSW, Australia,School of Psychiatry, University of New South Wales, Sydney, NSW, Australia
| | - C D Whelan
- Imaging Genetics Center, Stevens Neuroimaging & Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA
| | - M E Shenton
- Departments of Psychiatry and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA,VA Boston Healthcare System, Boston, MA, USA
| | - J S Kwon
- Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea
| | - G Spalletta
- Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy,Division of Neuropsychiatry, Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA
| | - F Spaniel
- National Institute of Mental Health, Klecany, Czech Republic,Third Faculty of Medicine, Charles University, Prague, Czech Republic
| | - E Sprooten
- Olin Neuropsychiatric Research Center, Institute of Living, Hartford Hospital and Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
| | - M Stäblein
- Laboratory for Neuroimaging, Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, Goethe University, Frankfurt/Main, Germany
| | - D J Stein
- Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa,Department of Psychiatry and MRC Unit on Anxiety and Stress Disorders, University of Cape Town, Cape Town, South Africa
| | - S Sundram
- Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia,Department of Psychiatry, School of Clinical Sciences, Monash University and Monash Health, Clayton, VIC, Australia
| | - Y Tan
- Beijing Huilongguan Hospital, Beijing, China
| | - S Tan
- Beijing Huilongguan Hospital, Beijing, China
| | - S Tang
- Chongqing Three Gorges Central Hospital, Chongqing, China
| | - H S Temmingh
- Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa
| | - L T Westlye
- NORMENT, KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway,Department of Psychology, University of Oslo, Oslo, Norway
| | - S Tønnesen
- NORMENT, KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - D Tordesillas-Gutierrez
- CIBERSAM, Centro Investigación Biomédica en Red Salud Mental, Santander, Spain,Neuroimaging Unit, Technological Facilities, Valdecilla Biomedical Research Institute IDIVAL, Santander, Spain
| | - N T Doan
- NORMENT, KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - J Vaidya
- Department of Psychiatry, University of Iowa, Iowa City, IA, USA
| | - N E M van Haren
- Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands
| | - C D Vargas
- Research Group in Psychiatry (GIPSI), Department of Psychiatry, Faculty of Medicine, Universidad de Antioquia, Medellín, Colombia
| | - D Vecchio
- Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy
| | - D Velakoulis
- Neuropsychiatry Unit, Royal Melbourne Hospital, Parkville, VIC, Australia
| | - A Voineskos
- Kimel Family Translational Imaging-Genetics Research Laboratory, Campbell Family Mental Health Research Institute, CAMH Department of Psychiatry, University of Toronto, Toronto, ON, Canada
| | - J Q Voyvodic
- Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Z Wang
- Beijing Huilongguan Hospital, Beijing, China
| | - P Wan
- Zhumadian Psychiatry Hospital, Henan Province, China
| | - D Wei
- Luoyang Fifth People's Hospital, Henan Province, China
| | - T W Weickert
- Schizophrenia Research Institute, Sydney, NSW, Australia,Neuroscience Research Australia, Sydney, NSW, Australia,School of Psychiatry, University of New South Wales, Sydney, NSW, Australia
| | - H Whalley
- University of Edinburgh, Edinburgh, UK
| | - T White
- Erasmus University Medical Center, Rotterdam, The Netherlands
| | - T J Whitford
- University of New South Wales, School of Psychiatry, Sydney, NSW, Australia
| | - J D Wojcik
- Harvard Medical School and Massachusetts Mental Health Center Public Psychiatry Division of the Beth Israel Deaconess, Medical Center, Boston, MA, USA
| | - H Xiang
- Chongqing Three Gorges Central Hospital, Chongqing, China
| | - Z Xie
- Worldwide Research and Development, Pfizer, Cambridge, MA, USA
| | - H Yamamori
- Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan
| | - F Yang
- Beijing Huilongguan Hospital, Beijing, China
| | - N Yao
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
| | - G Zhang
- Department of Computer Science and Electrical Engineering, University of Maryland, Baltimore, MD, USA
| | - J Zhao
- Centre for Neuroimaging and Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, National University of Ireland Galway, Galway, Ireland,School of Psychology, Shaanxi Normal University and Key Laboratory for Behavior and Cognitive Neuroscience of Shaanxi Province, Xi’an, Shaanxi, China
| | - T G M van Erp
- Department of Psychiatry and Human Behavior, University of California Irvine, Irvine, CA, USA
| | - J Turner
- Psychology Department & Neuroscience Institute, Georgia State University, Atlanta, GA, USA
| | - P M Thompson
- Imaging Genetics Center, Stevens Neuroimaging & Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA
| | - G Donohoe
- Centre for Neuroimaging and Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, National University of Ireland Galway, Galway, Ireland
| |
Collapse
|
20
|
Xiang H. Genome copy number variations of patients with unexplained recurrent spontaneous abortion. Fertil Steril 2017. [DOI: 10.1016/j.fertnstert.2017.07.869] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
21
|
Kaplan C, Houser D, Kemp F, Nielson N, Hsu A, Legris K, Brattich G, Xiang H, Ahene A, Jeffry U, Bellovin D, Borges L. FPA150, a novel B7-H4 therapeutic antibody with checkpoint blockade and ADCC activities. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx361.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
22
|
Hay CRM, Xiang H, Scott M, Collins PW, Liesner R, Dolan G, Hollingsworth R. The haemtrack home therapy reporting system: Design, implementation, strengths and weaknesses: A report from UK Haemophilia Centre Doctors Organisation. Haemophilia 2017; 23:728-735. [PMID: 28806858 DOI: 10.1111/hae.13287] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/06/2017] [Indexed: 11/28/2022]
Abstract
INTRODUCTION Haemtrack is an electronic home treatment diary for patients with inherited bleeding disorders, introduced in 2008. It aimed to improve the timeliness and completeness of patient-reported treatment records, to facilitate analysis of treatment and outcome trends. The system is easy to use, responsive and accessible. METHODS The software uses Microsoft technologies with a SQL Server database and an ASP.net website front-end, running on personal computers, android and I-phones. Haemtrack interfaces with the UK Haemophilia Centre Information System and the National Haemophilia Database (NHD). Data are validated locally by Haemophilia Centres and centrally by NHD. Data collected include as follows: treatment brand, dose and batch number, time/date of bleed onset and drug administration, reasons for treatment (prophylaxis, bleed, follow-up), bleed site, severity, pain-score and outcome. RESULTS Haemtrack was used by 90% of haemophilia treatment centres (HTCs) in 2015, registering 2683 patients using home therapy of whom 1923 used Haemtrack, entering >17 000 treatments per month. This included 68% of all UK patients with severe haemophilia A. Reporting compliance varied and 55% of patients reported ≥75% of potential usage. Centres had a median 78% compliance overall. A strategy for progressively improving compliance is in place. Age distribution and treatment intensity were similar in Haemtrack users/non-users with severe haemophilia treated prophylactically. CONCLUSION The Haemtrack system is a valuable tool that may improve treatment compliance and optimize treatment regimen. Analysis of national treatment trends and large-scale longitudinal, within-patient analysis of changes in regimen and/or product will provide valuable insights that will guide future clinical practice.
Collapse
Affiliation(s)
- C R M Hay
- University Department of Haematology, Manchester Royal Infirmary, Manchester, UK.,UK National Haemophilia Database, Manchester, UK
| | - H Xiang
- UK National Haemophilia Database, Manchester, UK
| | - M Scott
- UK National Haemophilia Database, Manchester, UK.,Institute of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
| | - P W Collins
- Haemophilia Comprehensive Care Centre, The School of Medicine, University of Cardiff, Cardiff, UK
| | - R Liesner
- The Haemophilia Centre, Great Ormond Street Hospital, London, UK
| | - G Dolan
- Thrombosis and Haemostasis Centre, Guys and St Thomas' Hospital, London, UJ
| | | |
Collapse
|
23
|
Pan F, Xiang H, Yan J, Hong L, Zhang L, Liu Y, Feng X, Cai C. Dendritic Cells from Rheumatoid Arthritis Patient Peripheral Blood Induce Th17 Cell Differentiation via miR-363/Integrin αv/TGF-β Axis. Scand J Immunol 2017; 85:441-449. [PMID: 28376277 DOI: 10.1111/sji.12550] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2016] [Revised: 02/22/2017] [Accepted: 03/13/2017] [Indexed: 12/28/2022]
Abstract
Dendritic cells (DCs) are critical regulators of immune responses. This study was to observe the effect of DCs from peripheral blood on the differentiation of Th17 in patients with rheumatoid arthritis (RA). Peripheral blood samples were collected from 30 patients with RA and 20 healthy controls, respectively. Flow cytometry results showed that in contrast to Treg cells, the proportion of Th17 cells in T cells and the Th17/Treg ratio were both increased in patients with RA. The RT-PCR results showed that Foxp3、ROR γt and miR-363 expression in PBMC of patients with RA were reduced, but the ITGAV expression was increased, which was negatively related to miR-363 expression. IL-17, TGF-β and IL-6 levels detected by ELISA were increased in peripheral blood serum of patients with RA. Moreover, we noted that the CD11C+ αν+ /CD11C+ DCs ratio was obvious increased in patients with RA and has positive correlation to the Th17/Treg ratio. In cocultured system, Th17 cell differentiation was significantly inhibited in the presence of ITGF-β suggesting that Th17 cell differentiation was controlled by active TGF-β (aTGF-β). After DCs transfecting with miR-363 mimics and cocultured with T cells, Th17 cell number, IL-17 level and ROR-γt expression were significantly reduced in the presence of latent TGF-β (ITGF-β). In addition, the integrin αv protein expression was both reduced in the presence of aTGF-β or ITGF-β. These data demonstrated that DCs induced Th17 cell differentiation through miR-363/Integrin αv/TGF-β pathway in patients with RA.
Collapse
Affiliation(s)
| | - H Xiang
- The Affiliated Hospotal of Hangzhou Normal University, Hangzhou, China
| | - J Yan
- The Affiliated Hospotal of Hangzhou Normal University, Hangzhou, China
| | - L Hong
- The Affiliated Hospotal of Hangzhou Normal University, Hangzhou, China
| | - L Zhang
- The Affiliated Hospotal of Hangzhou Normal University, Hangzhou, China
| | - Y Liu
- The Affiliated Hospotal of Hangzhou Normal University, Hangzhou, China
| | - X Feng
- The Affiliated Hospotal of Hangzhou Normal University, Hangzhou, China
| | - C Cai
- The Affiliated Hospotal of Hangzhou Normal University, Hangzhou, China
| |
Collapse
|
24
|
Ai QX, Zhang ZX, Xiang H. [Application of adjacent micro flap in the repair of skin defect in head and face]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2017; 31:1100-1102. [PMID: 29798250 DOI: 10.13201/j.issn.1001-1781.2017.14.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 02/20/2017] [Indexed: 11/12/2022]
Abstract
Objective:The aim of this study is to sum up the different surgical repair methods and techniques for the skin defect of head and face.Method:A retrospective study on 97 cases of the face and head skin defect caused by trauma and tumor resection in nearly five years, including 37 cases on nasal, 21 cases on cheek, 9 cases on frontal, 13 cases on temporal, and 17 cases on ear. After resecting skin lesion in security boundary, skin defect were repaired by transposition adjacent flap, zone vascular pedicle flap, myocutaneous flap and the mucosal flap.Result:Seventy-one cases of the postoperative flap healed and stitches discharged in a week; 24 cases of flap edge small necrosis in small, one flap occurred most necrosis, and one skin flap occurred infection and necrosis.Conclusion:Facial skin defect can be repaired primarily by various types of micro adjacent flap. Flap survival is closely related to surgical techniques and postoperative treatment. Retroauricular groove flap has been widely used to repair skin defect of multiple regions for ear.
Collapse
Affiliation(s)
- Q X Ai
- Department of Otorhinolaryngology Head and Neck Surgery, Enshi Central Hospital, Enshi, 445000, China
| | - Z X Zhang
- Department of Otorhinolaryngology Head and Neck Surgery, Enshi Central Hospital, Enshi, 445000, China
| | - H Xiang
- Department of Otorhinolaryngology Head and Neck Surgery, Enshi Central Hospital, Enshi, 445000, China
| |
Collapse
|
25
|
Tang C, Hou Y, Wang H, Wang K, Xiang H, Wan X, Xia Y, Li J, Wei W, Xu S, Lei Z, Pawlik TM, Wang H, Wu M, Shen F. Aspartate β-hydroxylase disrupts mitochondrial DNA stability and function in hepatocellular carcinoma. Oncogenesis 2017; 6:e362. [PMID: 28714949 PMCID: PMC5541716 DOI: 10.1038/oncsis.2017.64] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2017] [Revised: 06/12/2017] [Accepted: 06/14/2017] [Indexed: 02/07/2023] Open
Abstract
The mechanism of aberrant mitochondrial genome and function in hepatocellular carcinoma (HCC) remains largely unknown. Our previous study demonstrated an increased expression of aspartate β-hydroxylase (ASPH) in HCC tissues, which was associated with tumor invasiveness and a worse prognosis. Currently, we unexpectedly observed the presence of ASPH in purified mitochondrial protein fraction. In addition, immunostaining of both exogenously and endogenously expressed ASPH showed a colocalization with mitochondrial biomarkers. This study aimed to investigate whether the mitochondrial ASPH is involved in mitochondrial malfunction in HCC. Our results showed that ASPH overexpression in HCC tissues was correlated with decreased copy numbers of displacement loop (D-loop) and NADH dehydrogenase subunit 1 (ND-1) and enhanced D-loop mutation, suggesting the disrupted mitochondrial DNA (mtDNA) stability. The reduced mtDNA copy numbers were associated with aggressive clinicopathological features of HCC. The loss of mtDNA integrity induced by enforced expression of ASPH was accompanied with mitochondrial dysfunction, which was characterized by the aberrant mitochondrial membrane potential, decreased ATP generation and enhanced reactive oxygen species. In contrast, knocking down ASPH by siRNA in HCC cell lines showed the opposite impact on mtDNA integrity and function. Mass spectrometry and co-immunoprecipitation further identified that ASPH interacted with histone H2A member X (H2AX). ASPH overexpression diminished the interaction between H2AX and mitochondrial transcription factor A (mtTFA), an important DNA-binding protein for mtDNA replication, which then reduced the binding of mtTFA to D-loop region. Collectively, our results demonstrate that ASPH overexpression disrupts the mtDNA integrity through H2AX-mtTFA signal, thereby affecting mitochondrial functions in HCC.
Collapse
Affiliation(s)
- C Tang
- Department of Hepatic Surgery, The Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.,Department of Hepatobiliary Surgery, The Daping Hospital, Third Military Medical University, Chongqing, China
| | - Y Hou
- Department of Hepatic Surgery, The Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
| | - H Wang
- Department of Hepatic Surgery, The Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
| | - K Wang
- Department of Hepatic Surgery, The Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
| | - H Xiang
- Department of Hepatic Surgery, The Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
| | - X Wan
- Department of Clinical Database, The Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
| | - Y Xia
- Department of Hepatic Surgery, The Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
| | - J Li
- Department of Hepatic Surgery, The Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
| | - W Wei
- Department of Hepatic Surgery, The Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
| | - S Xu
- Department of Hepatic Surgery, The Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
| | - Z Lei
- Department of Hepatic Surgery, The Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
| | - T M Pawlik
- Department of Surgery, The Ohio State University, Wexner Medical Center, Columbus, OH, USA
| | - H Wang
- National Scientific Center for Liver Cancer, Second Military Medical University, Shanghai, China
| | - M Wu
- Department of Hepatic Surgery, The Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
| | - F Shen
- Department of Hepatic Surgery, The Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
| |
Collapse
|
26
|
Scott M, Nummi V, Lassila R, Xiang H, Hay CRM. Weekly recombinant FIX prophylaxis for severe haemophilia B in normal clinical practice: data from UKHCDO and Finland. Haemophilia 2017; 23:e240-e243. [DOI: 10.1111/hae.13228] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/11/2017] [Indexed: 11/29/2022]
Affiliation(s)
- M. Scott
- The Institute of Cancer Sciences; The University of Manchester; Manchester UK
- The UK National Haemophilia Database; Manchester UK
| | - V. Nummi
- Faculty of Medicine; University of Helsinki; Helsinki Finland
- Laboratory Services; Coagulation Disorders Unit; Department of Hematology and Comprehensive Cancer Center; Helsinki University Hospital; Helsinki Finland
| | - R. Lassila
- Faculty of Medicine; University of Helsinki; Helsinki Finland
- Laboratory Services; Coagulation Disorders Unit; Department of Hematology and Comprehensive Cancer Center; Helsinki University Hospital; Helsinki Finland
| | - H. Xiang
- The UK National Haemophilia Database; Manchester UK
| | - C. R. M. Hay
- The Institute of Cancer Sciences; The University of Manchester; Manchester UK
- The UK National Haemophilia Database; Manchester UK
| |
Collapse
|
27
|
Zhang YJ, Xiang H, Liu JS, Li D, Fang ZY, Zhang H. Study on the mechanism of AMPK signaling pathway and its effect on apoptosis of human hepatocellular carcinoma SMMC-7721 cells by curcumin. Eur Rev Med Pharmacol Sci 2017; 21:1144-1150. [PMID: 28338175] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
OBJECTIVE Liver cancer is a common malignant tumor in the digestive system. Curcumin is a kind of phenolic pigment, which is extracted from herbage and has a plenty of physiological roles in anti-inflammation, anti-oxidation and anti-tumor. In our study, human hepatoma SMMC-7721 cell lines were selected and treated with curcumin to detect its effects on the apoptosis and AMPK signaling pathway. MATERIALS AND METHODS Human liver cancer cell strain SMMC-7721 was cultured and treated with different curcumin concentrations for different times followed by measuring the changes of cell proliferation activity and cycle by MTT and flow cytometry, respectively. Protein expression of Bcl-2, Bax and Caspase-3 were tested by Western blot, and the activation level of AMPK was also detected. RESULTS Different concentrations of curcumin could inhibit the proliferation of tumor cells in a dose-dependent manner. After 48 h inhibition by curcumin with a concentration of 40 mmol/L, the inhibitory effect was more obvious with statistically significant (p<0.05). The number of human liver cancer SMMC-7721 cells increased in G1 stage and decreased in S stage after treated with different concentrations of curcumin. During the G1 stage to the S stage, inhibition occurred and the effect of curcumin intervention group with 40 mmol/L was more evident than that of 10 mmol/L group, 20 mmol/L group and the control group with statistically significant (p<0.05). SMMC-7721 cell stains had been intervening by curcumin with concentrations of 10 mmol/L, 20 mmol/L and 40 mmol/L for 12 h, 24 h and 48 h, as the drug concentration increased, the reaction time prolonged, the protein expressions of Bcl-2 and Survivin were significantly decreased and Bax protein expression was significantly increased (p<0.05). CONCLUSIONS Curcumin decreased the proliferation activity of tumor cells, increased the cell quantities in G1 stage and decreased the cell numbers in S stage in human liver cancer SMMC-7721 cells. The Bcl-2 and Survivin proteins were downregulated and Bax protein was upregulated; furthermore, the AMPK signaling pathway was activated.
Collapse
Affiliation(s)
- Y-J Zhang
- Department of Interventional Radiology & Vascular Surgery, Hunan Provincial People's Hospital, Changsha, China.
| | | | | | | | | | | |
Collapse
|
28
|
Li Z, Chen P, Guo Y, Xiang H, Mao Q, Zeng G, Xiao H, Xu D, Zhang X. 165 The Impact of Surgical Treatments for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia on Male Erectile Function: A Systematic Review and Network Meta-Analysis. J Sex Med 2017. [DOI: 10.1016/j.jsxm.2016.11.112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
29
|
Mao Q, Li Z, Chen P, Guo Y, Xiang H, Zeng G, Xu D, Cao B, Zhao K, Xiao H, Zhang X. 391 Upregulation of Phosphodiesterase Type 4 in the Hyperplastic Prostate. J Sex Med 2017. [DOI: 10.1016/j.jsxm.2016.11.270] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
30
|
Li Z, Chen P, Guo Y, Xiang H, Mao Q, Zeng G, Xiao H, Xu D, Zhang X, Cao B, Zhao K. 393 Upregulation of Oxytocin Receptor in the Hyperplastic Prostate. J Sex Med 2017. [DOI: 10.1016/j.jsxm.2016.11.272] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
31
|
Ding C, Xue W, Tian P, Ding X, Pan X, Yan H, Xiang H, Feng X, Hou J, Tian X, Li Y, Zheng J. Outcomes of standard dose EC-MPS with low exposure to CsA in DCD renal transplantation recipients with DGF. Int J Clin Pract 2016:8-15. [PMID: 26176940 DOI: 10.1111/ijcp.12661] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
AIMS The lower limit of exposure to cyclosporine A (CsA) has not yet been established in donation after cardiac death (DCD) renal transplantation recipients with delayed graft function (DGF) receiving enteric-coated mycophenolate sodium (EC-MPS) therapy. Stable and adequate mycophenolic acid (MPA) dosing may facilitate lower CsA exposure after DCD renal transplantation in recipients with DGF without compromising safety. METHODS A 12-month, single-centre open-label prospective trial was performed in our centre. According to their DGF risk index using the previous DGF prediction models, we divided up the patients on oral CsA into either a DGF group (n = 26) and no DGF group (n = 48). All of the patients initially received the standard EC-MPS dosing (1440 mg/day). The initial dose of CsA in the low risk of DGF group was 4.5 mg/kg/day and in the high risk of DGF group was 2.5 mg/kg/day. Efficacy parameters, safety and tolerability were assessed over a 12-month study period. RESULTS The incidence of DGF was 18.5% in the 162 DCD recipients. Between the DGF group and the no DGF group, the 1-year patient survival and graft survival were not significantly different. The incidence of BPAR was higher in the DGF group (26.9% vs. 8.3%, p = 0.032). Most patients in the DGF group had recovery of renal function after 1 month. The adverse events between the two groups were not significantly different. The daily EC-MPS doses of the DGF group were significantly higher than the no DGF group before the 6-month follow-up period. There were no significant differences between the two groups regarding the mean AUC levels during the follow-up period. CONCLUSIONS These results show that low expose CsA with standard dosing of EC-MPS and thymoglobulin was efficacious, safe and well-tolerated in DCD renal transplant recipients with DGF in China. Furthermore, stable and adequate MPA exposure helped to reduce the dose of and exposure to CsA. Thus, this may lead to less-induced nephrotoxicity and better renal function recovery.
Collapse
Affiliation(s)
- C Ding
- Department of Renal Transplantation, Nephropathy Hospital, The First Affiliated Hospital, Medical College of Xi'an Jiaotong University, Xi'an, China.,Institute of Organ Transplantation, Xi'an Jiaotong University, Xi'an, China
| | - W Xue
- Department of Renal Transplantation, Nephropathy Hospital, The First Affiliated Hospital, Medical College of Xi'an Jiaotong University, Xi'an, China.,Institute of Organ Transplantation, Xi'an Jiaotong University, Xi'an, China
| | - P Tian
- Department of Renal Transplantation, Nephropathy Hospital, The First Affiliated Hospital, Medical College of Xi'an Jiaotong University, Xi'an, China.,Institute of Organ Transplantation, Xi'an Jiaotong University, Xi'an, China
| | - X Ding
- Department of Renal Transplantation, Nephropathy Hospital, The First Affiliated Hospital, Medical College of Xi'an Jiaotong University, Xi'an, China.,Institute of Organ Transplantation, Xi'an Jiaotong University, Xi'an, China
| | - X Pan
- Department of Renal Transplantation, Nephropathy Hospital, The First Affiliated Hospital, Medical College of Xi'an Jiaotong University, Xi'an, China.,Institute of Organ Transplantation, Xi'an Jiaotong University, Xi'an, China
| | - H Yan
- Department of Renal Transplantation, Nephropathy Hospital, The First Affiliated Hospital, Medical College of Xi'an Jiaotong University, Xi'an, China.,Institute of Organ Transplantation, Xi'an Jiaotong University, Xi'an, China
| | - H Xiang
- Department of Renal Transplantation, Nephropathy Hospital, The First Affiliated Hospital, Medical College of Xi'an Jiaotong University, Xi'an, China.,Institute of Organ Transplantation, Xi'an Jiaotong University, Xi'an, China
| | - X Feng
- Department of Renal Transplantation, Nephropathy Hospital, The First Affiliated Hospital, Medical College of Xi'an Jiaotong University, Xi'an, China.,Institute of Organ Transplantation, Xi'an Jiaotong University, Xi'an, China
| | - J Hou
- Department of Renal Transplantation, Nephropathy Hospital, The First Affiliated Hospital, Medical College of Xi'an Jiaotong University, Xi'an, China.,Institute of Organ Transplantation, Xi'an Jiaotong University, Xi'an, China
| | - X Tian
- Department of Renal Transplantation, Nephropathy Hospital, The First Affiliated Hospital, Medical College of Xi'an Jiaotong University, Xi'an, China.,Institute of Organ Transplantation, Xi'an Jiaotong University, Xi'an, China
| | - Y Li
- Department of Renal Transplantation, Nephropathy Hospital, The First Affiliated Hospital, Medical College of Xi'an Jiaotong University, Xi'an, China.,Institute of Organ Transplantation, Xi'an Jiaotong University, Xi'an, China
| | - J Zheng
- Department of Renal Transplantation, Nephropathy Hospital, The First Affiliated Hospital, Medical College of Xi'an Jiaotong University, Xi'an, China.,Institute of Organ Transplantation, Xi'an Jiaotong University, Xi'an, China
| |
Collapse
|
32
|
Xiang H, Ma X, Shen N, Yue B, Zhang G, Chen B. Holocord spinal epidural abscess: Case report and literature review. Orthop Traumatol Surg Res 2016; 102:821-5. [PMID: 27341744 DOI: 10.1016/j.otsr.2016.05.004] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/13/2015] [Revised: 04/11/2016] [Accepted: 05/02/2016] [Indexed: 02/02/2023]
Abstract
Holocord spinal epidural abscess (SEA) is a rare condition. To our knowledge, five cases of SEA have been reported so far, and no consensus has been made on the treatment yet. In this article, we report a case of holocord SEA and review literature to further understanding of SEA. The advent of antibiotic treatment and the recognition of surgical debridement have been important in searching for alternatives to recovery, so the patient was treated surgically together with systemic antibiotics. The patient remained neurologically stable and continued to be clinically in good condition without any low back pain after 1 year. Surgical drainage, together with systemic antibiotics, is the main treatment choice for extensive SEAs. Although treatment should be considered that highlights the importance of examining the factors related to the health and condition of the patients and the anatomy and extent of the abscess, early surgical treatment associated with prolonged antibiotic treatment is necessary.
Collapse
Affiliation(s)
- H Xiang
- Department of orthopaedic surgery, Affiliated Hospital of Qingdao University, 266000 Qingdao, China
| | - X Ma
- Department of orthopaedic surgery, Affiliated Hospital of Qingdao University, 266000 Qingdao, China
| | - N Shen
- Department of rehabilitation, Affiliated Hospital of Qingdao University, 266000 Qingdao, China
| | - B Yue
- Department of orthopaedic surgery, Affiliated Hospital of Qingdao University, 266000 Qingdao, China
| | - G Zhang
- Department of orthopaedic surgery, Affiliated Hospital of Qingdao University, 266000 Qingdao, China
| | - B Chen
- Department of orthopaedic surgery, Affiliated Hospital of Qingdao University, 266000 Qingdao, China.
| |
Collapse
|
33
|
Cheng JX, Yao LL, Xiang H, Zhan YJ, Zhou P, Yuan M, Mei LP, Zhang Y. Cervical cytology ASCUS patients with HPV detection and clinical value. CLIN EXP OBSTET GYN 2016. [DOI: 10.12891/ceog3100.2016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]
|
34
|
Xiang H, Zhou Y, Huang P, Yu C, Liu J, Liu L, He P. Lethal poisoning with Gelsemium elegans in Guizhou, China. Public Health 2016; 136:185-7. [DOI: 10.1016/j.puhe.2016.02.031] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2015] [Accepted: 02/28/2016] [Indexed: 10/22/2022]
|
35
|
Yu HZ, Zhang F, Zhu PL, Pan W, Huang SJ, Xiang H. [Co-overexpression of human tissue kallikrein 1 and human metalloproteinase 1 tissue inhibitor inhibits neointima formation in the rat artery after balloon angioplasty]. Zhonghua Xin Xue Guan Bing Za Zhi 2016; 44:436-42. [PMID: 27220581 DOI: 10.3760/cma.j.issn.0253-3758.2016.05.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
OBJECTIVE To investigate the effects of adenovirus-mediated human tissue kallikrein 1(hTK-1) and/or human tissue metalloproteinase inhibitor 1 (hTIMP-1) gene delivery on the neointima formation in balloon-injured rat carotids and related mechanism. METHODS Forty-six male Sprague-Dawley rats were randomly assigned into 6 groups with the random number table: (1) sham-operated group(n=6), (2) angioplasty group (n=8), (3) vector virus group (n=8), (4) hTK-1 group (n=8), (5) hTIMP-1 group (n=8), (6) hTK-1-hTIMP-1 group (n=8). Except sham rats, all rats underwent carotid artery balloon injury and local delivery of saline or different recombined adenoviruses respectively. Rats were sacrificed 14 days later. Intima/media area ratio was assessed on hematoxylin-eosin stained tissue section. Immunofluorescence images stained for hTK-1, hTIMP-1 were obtained and analyzed by the confocal microscope for co-localization examination of hTK-1 and hTIMP-1. The protein expression levels of hTK-1, hTIMP-1, matrix metalloproteinases(MMP)-2 and MMP-9 were determined by Western blot. Immune histochemical staining for PCNA was also performed. RESULTS (1)Intima area, intima/media area ratio, PCNA, MMP-2 and MMP-9 levels were all significantly increased in rats underwent angioplasty (did or did not receive vector virus) compared with sham-operated rats (all P<0.01) while above parameters were similar between rats underwent angioplasty or vector virus delivery (all P>0.05). (2) The intima area of rats received vector virus, hTK-1, hTIMP-1 or dual gene transfer were (0.160±0.010), (0.110±0.015), (0.121±0.016) or (0.081±0.008) mm(2) respectively, intima area was similar between rats received hTK-1 or hTIMP-1 (P>0.05), differences were found between other groups (all P<0.01). The intima/media area ratio of rats received vector virus, hTK-1, hTIMP-1 or dual gene transfer were 2.035±0.117, 1.443±0.097, 1.522±0.078 or 0.972±0.072 respectively, no difference was found between rats received hTK-1 or hTIMP-1 in intima/media area ratio (all P>0.05), differences were found between other groups (all P<0.01). The MMP-2 and MMP-9 expression of rats received vector virus, hTK-1, hTIMP-1 or dual gene transfer were 0.817±0.036, 0.606±0.044, 0.571±0.061 or 0.455±0.030 and 0.745±0.057, 0.613±0.038, 0.582±0.050 or 0.473±0.038 respectively, no difference was found between rats received hTK-1 or hTIMP-1 in MMP-2 or MMP-9 expression (all P>0.05), differences were found between other groups (all P<0.01). The PCNA expression of rats received vector virus, hTK-1, hTIMP-1 or dual gene transfer were 0.065±0.007, 0.052±0.004, 0.055±0.007 or 0.031±0.004 respectively, no difference was found between rats received hTK-1or hTIMP-1 in PCNA expression (all P>0.05), differences were found between other groups (all P<0.01). CONCLUSION hTK-1 and hTIMP-1 co-overexpression may synergistically inhibit neointimal hyperplasia, attenuate vascular remodeling and reduce restenosis possibly via down regulating the expressions of PCNA, MMP-2 and MMP-9 in balloon-injured rat carotids.
Collapse
Affiliation(s)
- H Z Yu
- Department of Geriatrics, Fujian Provincial Hospital, Fujian Provincial Institute of Clinical Geriatrics, Provincial Clinical Medical College of Fujian Medical University, Fuzhou 350001, China
| | | | | | | | | | | |
Collapse
|
36
|
Xiang H, Zhang J, Hao YL, Fan J, Li FY, Wang LL, Ding LQ, Zhang X, Kuang XH, Gao XL. [The pathogenic gene screening in a cardiomyopathy pedigree of Yunnan province]. Zhonghua Xin Xue Guan Bing Za Zhi 2016; 44:416-420. [PMID: 27220577 DOI: 10.3760/cma.j.issn.0253-3758.2016.05.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
OBJECTIVE In this study, the sreening of candidate pathogenic gene is done among family members of an dilated cardiomyopathy(DCM)and hypertrophic cardiomyopathy (HCM) coexistence, and find the relationship between the genotype and the phenotype. METHODS The inheritance atlas was drawn, analysis of genetic characteristics and clinical phenotype.Peripheral venous blood samples of proband and family members were candidated gene exon high-throughput sequencing sub target capture, make the result compares with related database, ultimately screening the target area of the exon and mutations of candidate genes and then using bidirectional sequencing of Sanger to sequence other family members and the health group which were matching with gender and age to testify whether there is the above mutations. RESULTS In this family, the proband and his father carry three missense mutations, about TTNc.604 A>G(p.Lys202Glu)、TAZ c. 580A>G(p.Ile194Val)and MYH7c.730 T>C(p.Phe244Leu). The heart function of proband was failure, and accompanied malignant arrhythmia.But his father has no obvious clinical symptoms.In this family, the same genetic mutation of disease causing gene lead to different clinical phenotype, but different genetic mutation of disease causing gene lead to the same clinical phenotype.None of the mutations found in this family was found in the health group. CONCLUSION The patient of this family carries the genetic mutation of MYH7, TTN and TAZ.The patient of this family carries the composite mutation of MYH7(+) /TTN(+) heterozygous missense mutation and TAZ(+) /TTN(+) heterozygous missense mutation may be show the performance of the genetic characteristics of early onset, severe phenotype.
Collapse
Affiliation(s)
- H Xiang
- Department of Cardiology, Frist People's Hospital of Yunnan Province, Kunming 650032, China
| | | | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Cheng JX, Yao LL, Xiang H, Zhan YJ, Zhou P, Yuan M, Mei LP, Zhang Y. Cervical cytology ASCUS patients with HPV detection and clinical value. CLIN EXP OBSTET GYN 2016; 43:592-596. [PMID: 29734556] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
OBJECTIVE Patients whose cervical cytological exams produced a result of atypical squamous cells of undetermined significance (ASCUS) were asked to undergo human papillomavirus (HPV DNA) genotyping detection to assess the role of HPV infection in ASCUS. MATERIALS AND METHODS This study included 1,219 patients with ASCUS that were randomly divided into two groups. The first group contained 618 patients. These participants underwent colposcopy with cervical biopsy. The remaining 601 underwent colposcopy and biopsy with HPV DNA detection. RESULTS Out of the 56,000 patients with ASCUS who underwent ThinPrep cytology test (TCT) de- tection in the authors' hospitals' gynecological outpatient clinics, 1,604 were diagnosed with ASCUS (2.86%). Among the 1,219 patients with ASCUS, the rate of detection of cervical intraepithelial neoplasia (CIN) and cancerization was 22.89% (279/1,219). Among the 601 patients who underwent HPV testing, 182 were positive for high-risk HPV (30.28%). Among HPV-positive samples, the most common high-risk types were HPV16, and HPV58. The most common low-risk types were HPV6 and HPV 11. The rate of detection among high- risk patients who were positive for HPV and cervical carcinoma with intraepithelial neoplasia was 70.88% (129/182). The rate of detection for HPV-negative patients with cervical cancer with intraepithelial neoplasia was 11.55% (47/407). The rate of detection of high-risk HPV was higher than among patients who had not undergone HPV detection and among patients who were negative for HPV (p < 0.05). CONCLUSION The results of cervical cytological examination showed that the manner of progression from inflammation to cancer could differ considerably. HPV DNA examination is an effective means of categorizing and managing ASCUS.
Collapse
|
38
|
Ling YH, Quan Q, Xiang H, Zhu L, Chu MX, Zhang XR, Han CY. Expression profiles of differentially expressed genes affecting fecundity in goat ovarian tissues. Genet Mol Res 2015; 14:18743-52. [PMID: 26782524 DOI: 10.4238/2015.december.28.23] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Although RNA-Seq is an effective method for identifying and exploring novel functional genes in mammals, it has rarely been applied to study fertility-related genes in the goat. In this study, RNA-Seq was used to screen the estrus ovaries of uniparous and multiparous Anhui white goats (AWGs). In total, 15,890 genes were identified and 2201 of these were found to be differentially expressed between the genetic libraries from uniparous and multiparous goats. Compared to the uniparous library, 1583 genes were up-regulated and 618 genes were down-regulated in the multiparous library. The FER1L4 gene showed the level of highest up-regulation in the multiparous library, while SRD5A2 expression showed the greatest down-regulation. In order to determine the functions of FER1L4 and SRD5A2 in goats, the expression profiles of the two genes in different tissues from AWGs and Boer goats at diestrus were analyzed by quantitative PCR. FER1L4 and SRD5A2 showed tissue specific expression patterns and were highly expressed in ovaries from both AWGs and Boer goats. FER1L4 was more highly expressed in ovaries from multiparous than uniparous AWGs. In contrast, SRD5A2 was expressed at a lower level in multiparous AWGs. These results indicated that FER1L4 and SRD5A2 may be associated with the high fecundity of AWGs.
Collapse
Affiliation(s)
- Y H Ling
- College of Animal Science and Technology, Anhui Agricultural University, Hefei, Anhui, China.,Local Animal Genetic Resources Conservation and Biobreeding Laboratory of Anhui Province, Hefei, Anhui, China
| | - Q Quan
- College of Animal Science and Technology, Anhui Agricultural University, Hefei, Anhui, China.,College of Economy and Technology, Anhui Agricultural University, Hefei, Anhui, China
| | - H Xiang
- College of Animal Science and Technology, Anhui Agricultural University, Hefei, Anhui, China.,Local Animal Genetic Resources Conservation and Biobreeding Laboratory of Anhui Province, Hefei, Anhui, China
| | - L Zhu
- College of Animal Science and Technology, Anhui Agricultural University, Hefei, Anhui, China.,Local Animal Genetic Resources Conservation and Biobreeding Laboratory of Anhui Province, Hefei, Anhui, China
| | - M X Chu
- Key Laboratory of Farm Animal Genetic Resources and Germplasm Innovation of Ministry of Agriculture, Anhui, Beijing, China
| | - X R Zhang
- College of Animal Science and Technology, Anhui Agricultural University, Hefei, Anhui, China.,Local Animal Genetic Resources Conservation and Biobreeding Laboratory of Anhui Province, Hefei, Anhui, China
| | - C Y Han
- College of Animal Science and Technology, Anhui Agricultural University, Hefei, Anhui, China.,Local Animal Genetic Resources Conservation and Biobreeding Laboratory of Anhui Province, Hefei, Anhui, China
| |
Collapse
|
39
|
Chen K, Sun T, Xiang H. Effects of TRiEGME on water icing behavior in aviation turbine fuel. ASIA-PAC J CHEM ENG 2015. [DOI: 10.1002/apj.1949] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- K. Chen
- The Second Research Institute of Civil Aviation Administration of China Chengdu Sichuan 610041 China
| | - T. Sun
- School of Chemistry and Material Science Sichuan Normal University Chengdu Sichuan 610068 China
| | - H. Xiang
- The Second Research Institute of Civil Aviation Administration of China Chengdu Sichuan 610041 China
| |
Collapse
|
40
|
Chen C, Xiang JY, Hu W, Xie YB, Wang TJ, Cui JW, Xu Y, Liu Z, Xiang H, Xie Q. Identification of key micro-organisms involved in Douchi fermentation by statistical analysis and their use in an experimental fermentation. J Appl Microbiol 2015; 119:1324-34. [PMID: 26251195 DOI: 10.1111/jam.12917] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2015] [Revised: 07/09/2015] [Accepted: 07/24/2015] [Indexed: 11/30/2022]
Abstract
AIMS To screen and identify safe micro-organisms used during Douchi fermentation, and verify the feasibility of producing high-quality Douchi using these identified micro-organisms. METHODS AND RESULTS PCR-denaturing gradient gel electrophoresis (DGGE) and automatic amino-acid analyser were used to investigate the microbial diversity and free amino acids (FAAs) content of 10 commercial Douchi samples. The correlations between microbial communities and FAAs were analysed by statistical analysis. Ten strains with significant positive correlation were identified. Then an experiment on Douchi fermentation by identified strains was carried out, and the nutritional composition in Douchi was analysed. Results showed that FAAs and relative content of isoflavone aglycones in verification Douchi samples were generally higher than those in commercial Douchi samples. CONCLUSIONS Our study indicated that fungi, yeasts, Bacillus and lactic acid bacteria were the key players in Douchi fermentation, and with identified probiotic micro-organisms participating in fermentation, a higher quality Douchi product was produced. SIGNIFICANCE AND IMPACT OF THE STUDY This is the first report to analyse and confirm the key micro-organisms during Douchi fermentation by statistical analysis. This work proves fermentation micro-organisms to be the key influencing factor of Douchi quality, and demonstrates the feasibility of fermenting Douchi using identified starter micro-organisms.
Collapse
Affiliation(s)
- C Chen
- School of Life Sciences, Jilin University, Changchun, China
| | - J Y Xiang
- School of Life Sciences, Jilin University, Changchun, China
| | - W Hu
- School of Life Sciences, Jilin University, Changchun, China
| | - Y B Xie
- School of Life Sciences, Jilin Agricultural University, Changchun, China
| | - T J Wang
- School of Life Sciences, Jilin University, Changchun, China
| | - J W Cui
- School of Life Sciences, Jilin University, Changchun, China
| | - Y Xu
- School of Life Sciences, Jilin University, Changchun, China
| | - Z Liu
- School of Life Sciences, Jilin University, Changchun, China
| | - H Xiang
- School of Life Sciences, Jilin University, Changchun, China
- Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Sciences, Jilin University, Changchun, China
- National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China
| | - Q Xie
- School of Life Sciences, Jilin University, Changchun, China
- Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Sciences, Jilin University, Changchun, China
- National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China
| |
Collapse
|
41
|
Xiang H, Li B, Russo G, Behrman R, Lu H, Fernando H, Kachnic L. SU-E-T-541: Measurement of CT Density Model Variations and the Impact On the Accuracy of Monte Carlo (MC) Dose Calculation in Stereotactic Body Radiation Therapy for Lung Cancer. Med Phys 2015. [DOI: 10.1118/1.4924903] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
42
|
Ding C, Xue W, Tian P, Ding X, Pan X, Xiang H, Tian X, Li Y, Zheng J. Which is more suitable for kidney transplantation at the early post-transplantation phase in China - low dosing or standard dosing of enteric-coated mycophenolate sodium? Int J Clin Pract 2015:10-6. [PMID: 24673714 DOI: 10.1111/ijcp.12401] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/20/2023] Open
Abstract
AIMS To investigate the pharmacokinetics of enteric-coated mycophenolate sodium (EC-MPS) and the clinical outcome in kidney transplant recipients in the early post-transplantation phase. Then explain which regimen is more suitable for Chinese renal transplant recipients. METHODOLOGY In total, 60 de novo kidney transplant recipients treated with tacrolimus and steroids were randomised to receive EC-MPS at standard dose (SD; 1440 mg/day; n = 28) or low dose (LD; 1080 mg/day; n = 32). Efficacy parameters, safety and tolerability were assessed over a 6-month study period. Full mycophenolic acid (MPA) areas under the curve (AUCs) were completed on days 3 and 5, whereas a three-point limited sampling strategy (LSS) was utilised for MPA AUC assessments at 2 weeks and months 1, 3 and 6 (the LSS for three-time-point MPA AUC 0-12 h (mg h/l) = 15.99 + 0.87C1 h + 0.68C2 h + 7.85C4 h ; r(2) = 0.8670. RESULTS The mean AUC levels at day 3 and day 5 in the SD group were significantly higher than in the LD group (57.4 mg·h/l vs. 38.2 mg·h/l and 59.3 mg·h/l vs. 44.8 mg·h/l, respectively, p < 0.01). There was a trend for fewer clinically diagnosed acute rejections in the SD group vs. the LD group at 6 months (7.1% vs. 12.5%). This trend was also present when acute rejection was analysed as biopsy-proven cases. There were significantly more acute rejections (all definitions) in patients with MPA AUC levels < 30 mg·h/l compared with those with MPA AUC levels ≥ 30 mg·h/l within 6 months (p < 0.05). Renal function, incidence of infection and haematological disorders were not significantly different in either study group. CONCLUSIONS Early adequate MPA exposure in renal transplant recipients can be achieved with a higher starting dose. In addition, a SD regimen was as well-tolerated as a LD regimen. Furthermore, early adequate MPA exposure significantly lowered the rate of acute rejection without compromising safety and tolerability.
Collapse
Affiliation(s)
- C Ding
- Department of Renal Transplantation, Medical College of Xi'an Jiaotong University, Xi'an, China; Institute of Organ Transplantation, Xi'an Jiaotong University, Xi'an, China
| | | | | | | | | | | | | | | | | |
Collapse
|
43
|
Brahi OHD, Xiang H, Chen X, Farougou S, Zhao X. Mitogenome revealed multiple postdomestication genetic mixtures of West African sheep. J Anim Breed Genet 2015; 132:399-405. [PMID: 25865947 DOI: 10.1111/jbg.12144] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2014] [Accepted: 04/02/2014] [Indexed: 01/25/2023]
Abstract
Notable diversity observed within African ovine breeds makes them of great interests, but limited studies on genetic origins and domestications remain poorly understood. Here, we investigate the evolutionary status of West African native breeds, Djallonke and Sahelian sheep using mitogenome sequencing. Compared with other ovine mitogenome sequences, West African sheep were revealed a Eurasian origin, and the initially tamed sheep breeds in West Africa have been genetically mixed with each other and mixed with European breeds. Worldwide domestic sheep is deemed the Eurasian origin and migrated west to Europe and Africa and east to the Far East, in which dispersed and received selection for acclimation to autochthonic environment independently and ultimately evolved into different native breeds, respectively. Our results contribute to the comprehensive understanding of the domestic sheep origin and reveal multiple postdomestication genetic amelioration processes.
Collapse
Affiliation(s)
- O H D Brahi
- National Engineering Laboratory for Animal Breeding, China Agricultural University, Beijing, China.,Ministry of Agricultural Key Laboratory of Animal Genetics, Breeding and Reproduction, China Agricultural University, Beijing, China.,College of Animal Science and Technology, China Agricultural University, Beijing, China.,Laboratoire de Recherche en Biologie Appliquée, Ecole Polytechnique d'Abomey-Calavi, Université d'Abomey-Calavi, Cotonou, Bénin
| | - H Xiang
- National Engineering Laboratory for Animal Breeding, China Agricultural University, Beijing, China.,Ministry of Agricultural Key Laboratory of Animal Genetics, Breeding and Reproduction, China Agricultural University, Beijing, China.,College of Animal Science and Technology, China Agricultural University, Beijing, China
| | - X Chen
- National Engineering Laboratory for Animal Breeding, China Agricultural University, Beijing, China.,Ministry of Agricultural Key Laboratory of Animal Genetics, Breeding and Reproduction, China Agricultural University, Beijing, China.,College of Animal Science and Technology, China Agricultural University, Beijing, China
| | - S Farougou
- Laboratoire de Recherche en Biologie Appliquée, Ecole Polytechnique d'Abomey-Calavi, Université d'Abomey-Calavi, Cotonou, Bénin
| | - X Zhao
- National Engineering Laboratory for Animal Breeding, China Agricultural University, Beijing, China.,Ministry of Agricultural Key Laboratory of Animal Genetics, Breeding and Reproduction, China Agricultural University, Beijing, China.,College of Animal Science and Technology, China Agricultural University, Beijing, China
| |
Collapse
|
44
|
Cao B, Jiang H, Xiang H, Lin B, Qin Q, Zhang F, Kong W, Wei S, Liu L, Yan W, Nie S. Prevalence and influencing factors of depressive symptoms among women of reproductive age in the rural areas of Hubei, China. Public Health 2015; 129:465-74. [PMID: 25818016 DOI: 10.1016/j.puhe.2015.01.020] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2013] [Revised: 01/14/2015] [Accepted: 01/20/2015] [Indexed: 10/23/2022]
Abstract
OBJECTIVES Depression is one of the most common mental disorders and a major public health problem in the Chinese population, especially among women. The current study aims to understand prevalence of depression symptoms and provide detailed epidemiological factors associated with depression among reproductive women in rural areas which was paid less attention in previous surveys. STUDY DESIGN Cross-sectional study. METHODS Face-to-face household interviews were conducted on 1058 women (age: 15-49 years) in rural areas from July 2012 to August 2012. Questionnaires were used to investigate the influencing factors of depression among women. Pearson's χ(2), logistic regression analysis and structural equation modelling (SEM) were applied to analyze the related factors. RESULTS The prevalence of depression among women was 30.7% [95% confidence interval (CI): 27.9%-33.5%]. Compared with non-depressed individuals, those with depression were more likely to be short of social support [odd ratio (OR): 0.940, P < 0.001) and have no one to talk with (OR: 0.366, P < 0.001), to be dissatisfied with the house (OR: 2.673, P < 0.001) and economy (OR: 2.268, P < 0.01) of their family, and to have great pressure (OR: 2.099, P < 0.01), negative life events (OR: 1.485, P < 0.05) and physical diseases (OR: 1.364, P < 0.05). Pressure status, social support assessment, and socio-economic status were negatively related to depression (correlation coefficient: -0.57, -0.27 and 0.17). CONCLUSIONS The high prevalence of depression among reproductive women in rural areas is of particular concern. Factors associated with depression may assist health care administrations to identify and assess high-risk women and target strategies accordingly.
Collapse
Affiliation(s)
- B Cao
- Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - H Jiang
- Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - H Xiang
- Department of Epidemiology and Biostatistics, School of Public Health, Wuhan University, Wuhan, China
| | - B Lin
- Futian District Shenzhen City Center for Disease Control and Prevention, Shenzhen, Guangdong, China
| | - Q Qin
- Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - F Zhang
- Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - W Kong
- Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - S Wei
- Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - L Liu
- Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - W Yan
- Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
| | - S Nie
- Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
| |
Collapse
|
45
|
Xu B, Xiang H, Wei Q, Liu JQ, Xia YD, Yin J, Liu ZG. Two-dimensional graphene-like C2N: an experimentally available porous membrane for hydrogen purification. Phys Chem Chem Phys 2015; 17:15115-8. [DOI: 10.1039/c5cp01789k] [Citation(s) in RCA: 89] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The two-dimensional porous C2N sheet exhibits an extremely high selectivity and large permeance in favour of H2 among other atmospheric gases.
Collapse
Affiliation(s)
- B. Xu
- National Laboratory of Solid State Microstructures and Department of Materials Science and Engineering
- Nanjing University
- Nanjing
- China
| | - H. Xiang
- National Laboratory of Solid State Microstructures and Department of Materials Science and Engineering
- Nanjing University
- Nanjing
- China
| | - Q. Wei
- National Laboratory of Solid State Microstructures and Department of Materials Science and Engineering
- Nanjing University
- Nanjing
- China
| | - J. Q. Liu
- National Laboratory of Solid State Microstructures and Department of Materials Science and Engineering
- Nanjing University
- Nanjing
- China
| | - Y. D. Xia
- National Laboratory of Solid State Microstructures and Department of Materials Science and Engineering
- Nanjing University
- Nanjing
- China
| | - J. Yin
- National Laboratory of Solid State Microstructures and Department of Materials Science and Engineering
- Nanjing University
- Nanjing
- China
- Collaborative Innovation Center of Advanced Microstructures
| | - Z. G. Liu
- National Laboratory of Solid State Microstructures and Department of Materials Science and Engineering
- Nanjing University
- Nanjing
- China
- Collaborative Innovation Center of Advanced Microstructures
| |
Collapse
|
46
|
Liu T, Kishton RJ, Macintyre AN, Gerriets VA, Xiang H, Liu X, Abel ED, Rizzieri D, Locasale JW, Rathmell JC. Erratum: Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis. Cell Death Dis 2014. [PMCID: PMC4260751 DOI: 10.1038/cddis.2014.493] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
47
|
Abstract
CONTEXT Previous studies of medication errors have largely focused on healthcare facilities and have not reported generalizable national trends among out-of-hospital medication errors. OBJECTIVE We sought to understand U.S. trends in medication errors, including the age-related risks, the involved medications, and the medical outcomes. MATERIALS AND METHODS We performed a retrospective analysis of National Poison Data System (NPDS) data from the American Association of Poison Control Centers for years 2000-2012. Medication error cases were analyzed by age, gender, pharmaceutical involved, substance rank, dosing error type, management site, level of healthcare received, and medical outcome. Trends in medication error rates were analyzed using Poisson regression. RESULTS From 2000 to 2012, the NPDS recorded 2,913,924 calls reporting unintentional pharmaceutical-related errors that met inclusion criteria. Non-healthcare facility calls comprised 99.2% calls related to unintentional therapeutic errors. Eighty-seven percent of medication errors were managed on site. The annual medication error rate for all callers per 10,000 U.S. population increased significantly (p < 0.0001) by 69.8% from 2000 (4.98 calls per 10,000 population) to 2012 (8.46 calls per 10,000 population). Among adults aged 20 years and older, age was positively correlating (r = 0.96) with the rate of medication error. Analgesics were the most frequent pharmaceutical class involved in medication errors for ages 6-49 (N = 221,061). Among ages 20-49 years, opioid-related medication errors decreased by 7.9% from 2010 to 2012. Cardiovascular drugs were the leading source of injury among all ages (N = 14,440) and also the leading pharmaceutical class involved in medication errors among adults 50 years and older (N = 187,760). CONCLUSION Medication errors continue to be a source of preventable injury with increasing incidence across the out-of-hospital population.
Collapse
Affiliation(s)
- T J Brophy
- The Ohio State University College of Medicine , Columbus, OH , USA
| | | | | | | | | | | |
Collapse
|
48
|
Xiang Y, Liu T, Yang H, Gao F, Xiang H, Manyande A, Tian Y, Tian X. NRG1-ErbB signalling promotes microglia activation contributing to incision-induced mechanical allodynia. Eur J Pain 2014; 19:686-94. [PMID: 25159022 DOI: 10.1002/ejp.590] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/25/2014] [Indexed: 01/23/2023]
Affiliation(s)
- Y Xiang
- Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | | | | | | | | | | | | | | |
Collapse
|
49
|
Jin C, Qi R, Yin Y, Hu X, Duan L, Xu Q, Zhang Z, Zhong Y, Feng B, Xiang H, Gong Q, Liu Y, Lu G, Li L. Abnormalities in whole-brain functional connectivity observed in treatment-naive post-traumatic stress disorder patients following an earthquake. Psychol Med 2014; 44:1927-1936. [PMID: 24168716 DOI: 10.1017/s003329171300250x] [Citation(s) in RCA: 80] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
BACKGROUND Convergent studies have highlighted the dysfunction of the amygdala, prefrontal cortex and hippocampus in post-traumatic stress disorder (PTSD). However, only a few studies have investigated the functional connectivity between brain regions in PTSD patients during the resting state, which may improve our understanding of the neuropathophysiology of PTSD. The aim of this study was to investigate patterns of whole-brain functional connectivity in treatment-naive PTSD patients without co-morbid conditions who experienced the 8.0-magnitude earthquake in the Sichuan province of China. METHOD A total of 72 PTSD patients and 86 trauma-exposed non-PTSD controls participated in the resting-state functional magnetic resonance imaging study. All these subjects were recruited from the disaster zone of the 2008 Sichuan earthquake. Functional connectivities between 90 paired brain regions in PTSD patients were compared with those in trauma-exposed non-PTSD controls. Furthermore, Pearson correlation analysis was performed between significantly abnormal connectivities in PTSD patients and their clinician-administered PTSD scale (CAPS) scores. RESULTS Compared with non-PTSD controls, PTSD patients showed weaker positive connectivities between the middle prefrontal cortex (mPFC) and the amygdala, hippocampus, parahippocampal gyrus and rectus, as well as between the inferior orbitofrontal cortex and the hippocampus. In addition, PTSD patients showed stronger negative connectivity between the posterior cingulate cortex (PCC) and the insula. The CAPS scores in PTSD patients correlated negatively with the connectivity between the amygdala and the mPFC. CONCLUSIONS PTSD patients showed abnormalities in whole-brain functional connectivity, primarily affecting the connectivities between the mPFC and limbic system, and connectivity between the PCC and insula.
Collapse
Affiliation(s)
- C Jin
- Mental Health Institute,The Second Xiangya Hospital of Central South University,Hunan,People's Republic of China
| | - R Qi
- Department of Medical Imaging, Jinling Hospital, Clinical School of Medical College,Nanjing University,Nanjing.People's Republic of China
| | - Y Yin
- Mental Health Institute,The Second Xiangya Hospital of Central South University,Hunan,People's Republic of China
| | - X Hu
- Mental Health Institute,The Second Xiangya Hospital of Central South University,Hunan,People's Republic of China
| | - L Duan
- Mental Health Institute,The Second Xiangya Hospital of Central South University,Hunan,People's Republic of China
| | - Q Xu
- Department of Medical Imaging, Jinling Hospital, Clinical School of Medical College,Nanjing University,Nanjing.People's Republic of China
| | - Z Zhang
- Department of Medical Imaging, Jinling Hospital, Clinical School of Medical College,Nanjing University,Nanjing.People's Republic of China
| | - Y Zhong
- Department of Medical Imaging, Jinling Hospital, Clinical School of Medical College,Nanjing University,Nanjing.People's Republic of China
| | - B Feng
- Mianzhu Psychiatric Hospital,Erhuan Road and Mianzun Road, Deyang, Sichuan,People's Republic of China
| | - H Xiang
- Mental Health Center of Sichuan Province, Mianyang, Sichuan,People's Republic of China
| | - Q Gong
- Huaxi MR Research Center, Department of Radiology,West China Hospital of Sichuan University,Chengdu, Sichuan,People's Republic of China
| | - Y Liu
- Department of Psychiatry,University of Florida,Gainesville, FL,USA
| | - G Lu
- Department of Medical Imaging, Jinling Hospital, Clinical School of Medical College,Nanjing University,Nanjing.People's Republic of China
| | - L Li
- Mental Health Institute,The Second Xiangya Hospital of Central South University,Hunan,People's Republic of China
| |
Collapse
|
50
|
Xiang H, Qureshi M, De Armas R, Hirsch A, Katz M, Nicholas B, Keohan S, Lu H, Efstathiou J, Zietman A, Willins J, Kachnic J. SU-E-J-150: Impact of Intrafractional Prostate Motion On the Accuracy and Efficiency of Prostate SBRT Delivery: A Retrospective Analysis of Prostate Tracking Log Files. Med Phys 2014. [DOI: 10.1118/1.4888203] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|